https://curecurrent.com/trials/extracellular-vesicles-and-chemotherapy-induced-peripheral-neuropathy-27001https://curecurrent.com/trials/positron-emission-mammography-and-liquid-biopsy-in-women-with-high-risk-breast-screenings-27002https://curecurrent.com/trials/clinical-explorative-optical-breast-investigations-27003https://curecurrent.com/trials/chemotherapy-free-pcr-guided-strategy-with-trastuzumab-pertuzumab-and-t-dm1-in-her2-positive-early-breast-cancer-27004https://curecurrent.com/trials/pi3kbeta-inhibitor-azd8186-and-docetaxel-in-treating-patients-advanced-solid-tumors-with-pten-or-pik3cb-mutations-that-a-27005https://curecurrent.com/trials/together-after-cancer-27006https://curecurrent.com/trials/widening-aims-and-giving-patients-a-voice-for-expanded-structures-in-breast-cancer-care-jointly-developed-by-patients-an-27007https://curecurrent.com/trials/a-study-of-sh3765-tablets-in-combination-with-fulvestrant-in-patients-with-hr-her2-advanced-breast-cancer-27008https://curecurrent.com/trials/functional-near-infrared-spectroscopy-and-virtual-reality-relaxation-programs-for-pain-management-in-patients-with-cance-27009https://curecurrent.com/trials/neoadjuvant-oral-paclitaxel-plus-subcutaneous-pertuzumab-trastuzumab-in-patients-with-her2-positive-breast-cancer-27010https://curecurrent.com/trials/phesgo-maintenance-after-t-dxd-short-induction-for-her2-unresectable-locally-recurrent-or-metastatic-breast-cancer-27011https://curecurrent.com/trials/sacituzumab-govitecan-pembrolizumab-in-metastatic-tnbc-27012https://curecurrent.com/trials/exploring-the-potential-of-artificial-intelligence-for-earlier-breast-cancer-detection-a-retrospective-multi-reader-stud-27013https://curecurrent.com/trials/nurse-led-primary-healthcare-intervention-model-in-women-s-health-management-in-hong-kong-27014https://curecurrent.com/trials/enumeration-and-functional-analysis-of-circulating-tumor-cells-for-homologous-recombination-a-prospective-single-center-27015https://curecurrent.com/trials/an-integrated-genomic-approach-to-assess-genetic-risk-and-drug-sensitivity-27016https://curecurrent.com/trials/penguin-cold-caps-in-the-prevention-of-hair-loss-in-breast-cancer-patients-27017https://curecurrent.com/trials/evaluation-of-the-clinical-effectiveness-and-safety-of-acellular-dermal-matrix-sc-derm-recon-in-breast-reconstruction-27018https://curecurrent.com/trials/ribociclib-in-hormone-receptor-positive-her2-negative-early-breast-cancer-with-residual-disease-after-neoadjuvant-chemot-27019https://curecurrent.com/trials/application-and-comparison-of-68ga-ga-fapi-04-pet-18f-fdg-pet-and-contrast-enhanced-mri-in-predicting-pathological-respo-27020https://curecurrent.com/trials/neoadjuvant-til-and-response-adapted-chemoimmunotherapy-for-tnbc-27021https://curecurrent.com/trials/evaluation-of-safety-of-acellular-dermal-matrix-adm-in-breast-reconstruction-27022https://curecurrent.com/trials/effects-of-a-group-versus-individual-cognitive-training-program-on-chemotherapy-induced-cognitive-impairment-chemobrain-27023https://curecurrent.com/trials/remote-monitoring-and-symptom-management-digital-application-27024https://curecurrent.com/trials/nimbus-nivolumab-plus-ipilimumab-in-metastatic-hypermutated-her2-negative-breast-cancer-27025https://curecurrent.com/trials/a-precision-medicine-approach-smmart-act-for-the-treatment-of-patients-with-advanced-sarcoma-prostate-breast-ovarian-or-27026https://curecurrent.com/trials/the-soar-study-a-study-of-geriatric-assessment-and-exercise-for-older-adults-and-their-support-person-27027https://curecurrent.com/trials/a-single-center-retrospective-study-to-improve-the-visibility-of-breast-tissue-marker-clips-in-breast-tissue-and-axillar-27028https://curecurrent.com/trials/metformin-hydrochloride-in-preventing-breast-cancer-in-patients-with-atypical-hyperplasia-or-in-situ-breast-cancer-27029https://curecurrent.com/trials/sub-topic-four-clinical-translation-of-original-radioactive-drugs-for-precision-diagnosis-and-treatment-of-gastrointesti-27030https://curecurrent.com/trials/prospective-study-of-immune-alterations-in-operable-breast-and-ovarian-carcinoma-27031https://curecurrent.com/trials/exercise-in-metastatic-breast-cancer-embody-27032https://curecurrent.com/trials/testing-radiation-and-her2-targeted-therapy-versus-her2-targeted-therapy-alone-for-low-risk-her2-positive-breast-cancer-27033https://curecurrent.com/trials/preoperative-chemotherapy-pembrolizumab-and-low-or-high-dose-radiation-in-an-expansion-cohort-of-node-triple-negative-br-27034https://curecurrent.com/trials/diet-drive-gut-microbiome-and-outcome-in-patients-with-early-stage-triple-negative-breast-cancer-undergoing-neoadjuvant-27035https://curecurrent.com/trials/feasibility-and-tolerability-of-transcranial-direct-current-stimulation-with-concurrent-cognitive-training-27036https://curecurrent.com/trials/an-open-label-multicenter-non-randomized-expanded-access-protocol-eap-designed-to-provide-leronlimab-to-patients-with-lo-27037https://curecurrent.com/trials/determining-individual-preferences-for-gynecomastia-avoidance-dingo-stage-1-27038https://curecurrent.com/trials/attention-and-interpretation-modification-aim-for-fear-of-cancer-recurrence-an-intervention-development-study-27039https://curecurrent.com/trials/music-therapy-in-patients-with-breast-cancer-impact-27040https://curecurrent.com/trials/endocrine-therapy-with-or-without-abemaciclib-ly2835219-following-surgery-in-participants-with-breast-cancer-27041https://curecurrent.com/trials/the-effect-of-simulation-based-breast-health-education-on-breast-cancer-awareness-and-breast-self-examination-practices-27042https://curecurrent.com/trials/a-dietary-supplement-resistant-potato-starch-for-reducing-musculoskeletal-symptoms-in-individuals-planning-to-receive-ar-27043https://curecurrent.com/trials/clinical-outcomes-and-patient-satisfaction-with-use-of-the-amma-system-27044https://curecurrent.com/trials/tamoxifen-and-pegylated-liposomal-doxorubicin-for-the-treatment-of-patients-with-metastatic-or-inoperable-locally-advanc-27045https://curecurrent.com/trials/assessment-of-cognitive-function-in-breast-cancer-and-lymphoma-patients-receiving-chemotherapy-27046https://curecurrent.com/trials/pre-pectoral-implant-for-immediate-breast-reconstruction-using-single-port-endoscopy-in-prophylactic-indication-27047https://curecurrent.com/trials/real-world-patient-reported-outcome-of-sacituzumab-govitecan-in-chinese-metastatic-breast-cancer-27048https://curecurrent.com/trials/standard-of-care-chemotherapy-plus-pembrolizumab-for-breast-cancer-27049https://curecurrent.com/trials/comparison-of-ultrasound-and-breast-mri-for-breast-cancer-detection-27050https://curecurrent.com/trials/pembrolizumab-irx-2-and-chemotherapy-in-triple-negative-breast-cancer-27051https://curecurrent.com/trials/elacestrant-with-without-triptorelin-in-premenopausal-women-with-luminal-breast-cancer-27052https://curecurrent.com/trials/cancer-awareness-among-syrian-migrants-27053https://curecurrent.com/trials/evaluation-of-circulating-tumor-cells-ctc-relevance-in-breast-cancer-follow-up-using-the-screencell-device-27054https://curecurrent.com/trials/effects-of-chemotherapy-on-cognitive-function-in-breast-cancer-patients-non-cancer-control-subjects-with-optional-sub-st-27055https://curecurrent.com/trials/b-brilliant-revelation-comparision-study-27056https://curecurrent.com/trials/optimize-neoadjuvant-therapy-in-her2-positive-early-stage-breast-cancer-27057https://curecurrent.com/trials/adie-bc-aligning-dimensions-of-interoceptive-experience-in-breast-cancer-survivors-27058https://curecurrent.com/trials/phase-ib-ii-study-of-zanidatamab-plus-tucatinib-and-chemotherapy-in-her2-positive-advanced-breast-cancer-27059https://curecurrent.com/trials/endoscopic-skin-sparing-vs-conventional-mastectomy-for-wound-complications-in-bc-27060https://curecurrent.com/trials/radiation-therapy-and-docetaxel-followed-by-standard-therapy-in-treating-women-with-breast-cancer-27061https://curecurrent.com/trials/a-pilot-trial-of-just-ask-to-increase-discussions-about-breast-cancer-clinical-trials-27062https://curecurrent.com/trials/autologous-fat-grafting-in-radiated-soft-tissue-reconstruction-27063https://curecurrent.com/trials/bioequivalence-anda-snp-clinical-study-raloxifene-and-single-nucleotide-polymorphisms-27064https://curecurrent.com/trials/de-escalation-of-breast-radiation-trial-for-hormone-sensitive-her-2-negative-oncotype-recurrence-score-less-than-or-equa-27065https://curecurrent.com/trials/intraoperative-margin-assessment-in-breast-cancer-with-hsi-raman-27066https://curecurrent.com/trials/vitamin-d-and-breast-cancer-does-weight-make-a-difference-27067https://curecurrent.com/trials/efficacy-and-safety-of-atezolizumab-plus-capecitabine-adjuvant-therapy-for-triple-receptor-negative-breast-cancer-27068https://curecurrent.com/trials/phase-iii-trial-of-camrelizumab-apatinib-eribulin-vs-physician-s-choice-chemotherapy-in-advanced-triple-negative-breast-27069https://curecurrent.com/trials/cancer-experience-registry-cer-for-cancer-patients-and-caregivers-27070https://curecurrent.com/trials/impact-of-a-telephonic-monitoring-during-inter-treatment-intervals-on-emotional-state-quality-of-life-and-toxicities-on-27071https://curecurrent.com/trials/trastuzumab-emtansine-t-dm1-after-trastuzumab-deruxtecan-t-dxd-in-her2-positive-breast-cancer-in-korea-27072https://curecurrent.com/trials/hypofractionated-radiation-by-cyberknife-as-a-mean-of-the-tumor-site-s-radiation-after-conventional-breast-radiation-27073https://curecurrent.com/trials/portable-scalp-cooling-system-pscs-to-prevent-hair-loss-for-breast-cancer-patients-cooler-heads-27074https://curecurrent.com/trials/active-mammography-and-counseling-27075https://curecurrent.com/trials/novel-body-composition-measurements-in-association-with-outcomes-of-breast-reconstruction-reconstruction-27076https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-tolerability-of-tos-358-in-women-with-hr-her2-breast-cancer-27077https://curecurrent.com/trials/individualizing-approaches-to-surveillance-mammography-in-older-breast-cancer-survivors-the-i-mammo-study-27078https://curecurrent.com/trials/a-study-of-jskn003-versus-trastuzumab-in-combination-with-pertuzumab-and-docetaxel-as-first-line-treatment-for-her2-posi-27079https://curecurrent.com/trials/ai-assisted-chemotherapy-side-effect-management-27080https://curecurrent.com/trials/metformin-hydrochloride-and-doxycycline-in-treating-patients-with-localized-breast-or-uterine-cancer-27081https://curecurrent.com/trials/evexomostat-plus-pi3k-or-akt-inhibitor-and-fulvestrant-in-patients-with-a-pi3k-alteration-and-hr-her2-breast-cancer-27082https://curecurrent.com/trials/sacituzumab-govitecan-in-primary-her2-negative-breast-cancer-27083https://curecurrent.com/trials/combined-breast-mri-and-biomarker-strategies-in-identifying-high-risk-breast-cancer-patients-27084https://curecurrent.com/trials/the-prognostic-role-of-tils-and-cd8-t-cells-in-operable-breast-cancer-27085https://curecurrent.com/trials/the-effect-of-acupuncture-on-cancer-related-cognitive-difficulties-27086https://curecurrent.com/trials/predict-rd-ctdna-surveillance-in-tnbc-with-residual-disease-27087https://curecurrent.com/trials/areola-preservation-in-nsm-with-nipple-involvement-27088https://curecurrent.com/trials/safety-and-immune-response-to-a-mammaglobin-a-dna-vaccine-in-breast-cancer-patients-undergoing-neoadjuvant-endocrine-the-27089https://curecurrent.com/trials/verification-of-range-accuracy-and-correlation-with-clinical-toxicity-using-offline-pet-ct-for-hypofractionated-proton-r-27090https://curecurrent.com/trials/cancer-activity-and-lifestyle-measurement-study-27091https://curecurrent.com/trials/predictive-clinical-and-biological-parameters-in-breast-cancer-27092https://curecurrent.com/trials/effects-of-a-telerehabilitation-intervention-in-the-management-of-complications-after-breast-cancer-surgery-27093https://curecurrent.com/trials/evaluation-of-improved-onboard-patient-imaging-27094https://curecurrent.com/trials/open-multi-cohort-study-of-the-first-phase-of-safety-of-a-drug-based-on-double-recombinant-vaccinia-virus-vv-gmcsf-lact-27095https://curecurrent.com/trials/safety-and-efficacy-of-bkm120-and-lapatinib-in-her2-pi3k-activated-trastuzumab-resistant-advanced-breast-cancer-27096https://curecurrent.com/trials/continues-cicatricial-perfusion-of-ropivacaine-versus-placebo-after-mastectomy-rehabilitation-after-treatment-27097https://curecurrent.com/trials/fmd-and-neoadjuvant-chemo-immunotherapy-in-tnbc-27098https://curecurrent.com/trials/analyzing-a-new-mechanism-in-response-to-tamoxifen-therapy-in-breast-cancer-patients-27099https://curecurrent.com/trials/breast-and-cervical-cancer-awareness-training-in-visually-impaired-women-27100https://curecurrent.com/trials/a-real-world-study-of-inavolisib-in-patients-with-hr-positive-her2-negative-pik3ca-mutated-advanced-breast-cancer-27101https://curecurrent.com/trials/a-study-of-the-therabionic-p1-device-in-breast-cancer-27102https://curecurrent.com/trials/a-phase-iii-study-of-bevacizumab-and-paclitaxel-in-combination-with-atezolizumab-as-a-treatment-for-locally-advanced-unr-27103https://curecurrent.com/trials/digital-mind-body-therapy-for-neoadjuvant-breast-cancer-27104https://curecurrent.com/trials/independent-external-blinded-retrospective-validation-of-an-ai-based-prognostic-assay-in-er-positive-her2-negative-early-27105https://curecurrent.com/trials/atezolizumab-stereotactic-radiation-in-triple-negative-breast-cancer-and-brain-metastasis-27106https://curecurrent.com/trials/effectiveness-of-a-visual-biofeedback-program-versus-conventional-physiotherapy-on-shoulder-mobility-strength-and-functi-27107https://curecurrent.com/trials/real-world-bicohort-observational-study-of-a-pertuzumab-biosimilar-in-the-treatment-of-breast-cancer-in-the-neoadjuvant-27108https://curecurrent.com/trials/axillary-reverse-mapping-in-preventing-lymphedema-in-patients-with-breast-cancer-undergoing-axillary-lymph-node-dissecti-27109https://curecurrent.com/trials/real-world-treatment-patterns-of-endocrine-based-therapy-among-patients-with-hormone-receptor-positive-human-epidermal-g-27110https://curecurrent.com/trials/phase-ib-ii-study-of-ly2780301-in-combination-with-weekly-paclitaxel-in-her2-metastatic-breast-cancer-27111https://curecurrent.com/trials/reinvigorating-tnbc-response-to-immunotherapy-with-combination-myeloid-inhibition-and-radiation-27112https://curecurrent.com/trials/at-home-cancer-directed-therapy-versus-in-clinic-for-the-treatment-of-patients-with-advanced-cancer-27113https://curecurrent.com/trials/a-real-world-study-on-the-impact-of-different-adjuvant-treatment-regimens-on-prognosis-in-non-pcr-patients-with-her2-pos-27114https://curecurrent.com/trials/zunsemetinib-in-combination-with-capecitabine-in-patients-with-hormone-receptor-positive-and-her2-negative-metastatic-br-27115https://curecurrent.com/trials/the-comparison-between-m-e-bcs-and-c-o-bcs-27116https://curecurrent.com/trials/durvalumab-with-trastuzumab-and-pertuzumab-in-her2-enriched-breast-cancer-27117https://curecurrent.com/trials/effects-of-physical-activity-in-early-stage-hormone-receptor-positive-breast-cancer-patients-27118https://curecurrent.com/trials/hypofractionated-regional-nodal-irradiation-in-breast-cancer-27119https://curecurrent.com/trials/breast-cancer-study-of-preoperative-pembrolizumab-radiation-27120https://curecurrent.com/trials/study-to-evaluate-the-impact-of-the-use-of-alternative-and-complementary-therapies-on-therapeutic-adherence-in-patients-27121https://curecurrent.com/trials/a-multicohort-study-of-toripalimab-in-combination-with-investigator-selected-chemotherapy-for-advanced-her2-negative-bre-27122https://curecurrent.com/trials/an-open-label-prospective-study-to-evaluate-the-efficacy-and-safety-of-pegfilgrastim-in-triple-negative-breast-cancer-pa-27123https://curecurrent.com/trials/a-study-of-tetrathiomolybdate-tm-plus-capecitabine-27124https://curecurrent.com/trials/astraea-reinvigorating-response-to-immunotherapy-in-metastatic-tnbc-with-combination-myeloid-inhibition-and-radiation-27125https://curecurrent.com/trials/dose-reduced-docetaxel-with-cyclophosphamide-for-the-treatment-of-vulnerable-older-women-with-stage-i-iii-her2-negative-27126https://curecurrent.com/trials/clinical-study-on-adjuvant-therapy-of-tqb3616-combined-with-endocrine-therapy-compared-with-placebo-combined-with-endocr-27127https://curecurrent.com/trials/quality-of-life-in-breast-cancer-survivors-who-were-pregnant-during-their-cancer-treatment-27128https://curecurrent.com/trials/prevention-of-cipn-using-compressive-therapy-27129https://curecurrent.com/trials/a-feasibility-trial-of-a-web-based-app-intervention-in-hormone-positive-breast-cancer-patients-to-improve-adherence-to-e-27130https://curecurrent.com/trials/high-dose-radiation-therapy-with-pembrolizumab-and-chemotherapy-for-the-treatment-of-patients-with-pd-l1-positive-metast-27131https://curecurrent.com/trials/quantitative-mri-assessment-of-breast-cancer-therapy-response-27132https://curecurrent.com/trials/auricular-point-stimulation-plus-dexamethasone-for-nausea-and-vomiting-caused-by-docetaxel-plus-cyclophosphamide-27133https://curecurrent.com/trials/senovie-france-therapeutic-mobility-and-breast-cancer-27134https://curecurrent.com/trials/comparing-restriction-spectrum-imaging-rsi-to-conventional-and-abbreviated-breast-mri-for-breast-cancer-screening-27135https://curecurrent.com/trials/cf33-hnis-antipdl1-for-the-treatment-of-metastatic-triple-negative-breast-cancer-27136https://curecurrent.com/trials/optimization-of-dynamic-neoadjuvant-therapy-strategies-for-her2-positive-breast-cancer-based-on-her2-pet-ct-molecular-im-27137https://curecurrent.com/trials/avelumab-with-binimetinib-sacituzumab-govitecan-or-liposomal-doxorubicin-in-treating-stage-iv-or-unresectable-recurrent-27138https://curecurrent.com/trials/prospective-construction-and-validation-of-a-prognostic-score-to-identify-among-patients-with-metastatic-breast-cancer-t-27139https://curecurrent.com/trials/auricular-point-stimulation-plus-dexamethasone-for-nausea-and-vomiting-caused-by-trastuzumab-deruxtecan-27140https://curecurrent.com/trials/eclectic-estrotep-and-circulating-biomarkers-for-er-positive-her2-negative-metastatic-breast-cancer-patients-27141https://curecurrent.com/trials/surgical-glove-compression-to-prevent-paclitaxel-neuropathy-27142https://curecurrent.com/trials/proton-vs-photon-imrt-toxicity-in-breast-cancer-27143https://curecurrent.com/trials/accelerated-radiation-therapy-art-to-the-breast-and-nodal-stations-27144https://curecurrent.com/trials/effect-of-high-dose-vitamin-d-on-cancer-biomarkers-and-breast-cancer-tumors-27145https://curecurrent.com/trials/factors-associated-with-breast-cancer-risks-and-outcomes-27146https://curecurrent.com/trials/the-predict-registry-27147https://curecurrent.com/trials/evaluation-of-the-possible-safety-and-efficacy-of-dapagliflozin-in-the-prophylaxis-of-doxorubicin-induced-cardiotoxicity-27148https://curecurrent.com/trials/study-of-pf-07248144-in-advanced-or-metastatic-solid-tumors-27149https://curecurrent.com/trials/the-effect-of-cold-salt-water-foot-bath-on-the-development-of-chemotherapy-induced-peripheral-neuropathy-27150https://curecurrent.com/trials/mammography-and-breast-arterial-calcification-an-information-sharing-trial-27151https://curecurrent.com/trials/toripalimab-in-combination-with-nab-paclitaxel-for-patients-with-metastatic-or-recurrent-triple-negative-breast-cancer-t-27152https://curecurrent.com/trials/evaluation-of-quality-of-life-after-facial-hyaluroic-acid-injections-following-treatment-for-breast-cancer-27153https://curecurrent.com/trials/capecitabine-7-7-schedule-with-neratinib-in-patients-with-metastatic-her2-positive-breast-cancer-27154https://curecurrent.com/trials/impact-of-regional-anesthesia-on-chronic-post-operative-pain-27155https://curecurrent.com/trials/pembrolizumab-with-intratumoral-injection-of-clostridium-novyi-nt-27156https://curecurrent.com/trials/luminal-breast-cancer-cryoablation-27157https://curecurrent.com/trials/a-study-of-selpercatinib-loxo-292-in-participants-with-advanced-solid-tumors-ret-fusion-positive-solid-tumors-and-medull-27158https://curecurrent.com/trials/utidelone-combined-with-bevacizumab-in-the-treatment-of-2-lines-of-her-2-negative-advanced-breast-cancer-27159https://curecurrent.com/trials/molecular-surveillance-in-early-breast-cancer-using-the-tumor-informed-ctdna-assay-myriad-genetics-precise-mrd-test-a-pr-27160https://curecurrent.com/trials/breast-cancer-evolution-during-neoadjuvant-systemic-therapy-27161https://curecurrent.com/trials/effects-of-instrument-assisted-constant-speed-injection-versus-manual-injection-on-pain-from-large-volume-subcutaneous-i-27162https://curecurrent.com/trials/decision-making-tool-in-supporting-decision-making-in-contralateral-prophylactic-mastectomy-in-patients-with-newly-diagn-27163https://curecurrent.com/trials/fuscc-refractory-tnbc-platform-study-future2-0-27164https://curecurrent.com/trials/efficacy-of-the-maeva-program-meditation-acceptance-and-commitment-to-values-among-patients-treated-for-breast-cancer-27165https://curecurrent.com/trials/a-phase-iii-study-of-jskn016-versus-treatment-of-physician-s-choice-in-patients-with-triple-negative-breast-cancer-who-h-27166https://curecurrent.com/trials/study-of-zelenectide-pevedotin-in-participants-with-advanced-breast-cancer-27167https://curecurrent.com/trials/a-bidirectional-cohort-study-on-prophylactic-resection-surgery-in-populations-at-moderate-to-high-risk-for-hereditary-ov-27168https://curecurrent.com/trials/study-to-determine-the-safety-and-efficacy-of-ribociclib-in-combination-with-hormone-therapy-and-hypofractionated-radiot-27169https://curecurrent.com/trials/selumetinib-and-olaparib-in-solid-tumors-27170https://curecurrent.com/trials/agnostic-therapy-in-rare-solid-tumors-27171https://curecurrent.com/trials/electroacupuncture-therapy-in-reducing-chronic-pain-in-patients-after-breast-cancer-treatment-27172https://curecurrent.com/trials/gcc-1366-anti-proliferative-response-to-neoadjuvant-ais-in-overweight-and-obese-patients-27173https://curecurrent.com/trials/extended-sentinel-lymph-node-biopsy-with-methylene-blue-single-tracer-post-neoadjuvant-therapy-for-node-positive-breast-27174https://curecurrent.com/trials/assessing-effectiveness-and-implementation-of-an-ehr-tool-to-assess-heart-health-among-survivors-27175https://curecurrent.com/trials/js207-combination-therapy-in-triple-negative-breast-cancer-27176https://curecurrent.com/trials/tumor-microenvironment-spatial-interaction-to-identify-markers-of-resistance-to-therapy-in-her2-breast-cancer-patients-27177https://curecurrent.com/trials/acute-radiation-dermatitis-after-adjuvant-radiotherapy-for-breast-cancer-patients-with-the-use-of-silver-plated-technolo-27178https://curecurrent.com/trials/evaluating-ovarian-toxicity-outcomes-following-immunotherapy-in-patients-with-triple-negative-breast-cancer-tnbc-27179https://curecurrent.com/trials/hismar-intraoperative-margin-assessment-using-the-histolog-scanner-to-reduce-reoperation-in-breast-conserving-surgery-27180https://curecurrent.com/trials/therapeutic-nipple-sparing-mastectomy-27181https://curecurrent.com/trials/circulating-mirnas-as-biomarkers-of-hormone-sensitivity-in-breast-cancer-27182https://curecurrent.com/trials/pharmacology-of-adjuvant-hormonotherapy-in-breast-cancer-27183https://curecurrent.com/trials/fulvestrant-ipatasertib-and-cdk4-6-inhibition-in-metastatic-er-her2-breast-cancer-patients-without-ctdna-suppression-27184https://curecurrent.com/trials/feasibility-study-for-the-determination-of-oxysterols-in-patients-with-breast-cancer-receiving-hormonal-therapy-with-tam-27185https://curecurrent.com/trials/neoadjuvant-shr-a1811-combined-with-pertuzumab-in-her2-positive-breast-cancer-an-exploratory-clinical-study-27186https://curecurrent.com/trials/managed-access-programs-for-byl719-alpelisib-27187https://curecurrent.com/trials/intervention-to-improve-the-delivery-of-follow-up-care-for-low-risk-breast-cancer-27188https://curecurrent.com/trials/the-effect-of-psychosocial-support-on-improving-breast-cancer-patients-response-to-medical-treatment-27189https://curecurrent.com/trials/an-integrated-optimization-of-surgery-and-radiotherapy-techniques-to-improve-cosmetic-outcome-and-quality-of-life-in-bre-27190https://curecurrent.com/trials/prospective-evaluation-of-pencil-beam-scanning-proton-therapy-for-previously-irradiated-tumors-27191https://curecurrent.com/trials/baduanjin-exercise-on-upper-limb-dysfunction-among-breast-cancer-survivors-27192https://curecurrent.com/trials/a-phase-iia-study-to-evaluate-nbq72s-27193https://curecurrent.com/trials/reaching-for-evidence-based-chemotherapy-use-in-endocrine-sensitive-breast-cancer-27194https://curecurrent.com/trials/phase-i-ii-evaluate-the-safety-and-efficacy-of-blex-404-with-docetaxel-in-patients-with-advanced-metastatic-triple-negat-27195https://curecurrent.com/trials/the-impact-of-the-gene-recurrence-score-on-chemotherapy-prescribing-in-er-positive-lymph-node-positive-early-stage-breas-27196https://curecurrent.com/trials/phase-ib-ii-trial-of-copanlisib-in-combination-with-trastuzumab-in-her2-positive-breast-cancer-panther-study-27197https://curecurrent.com/trials/diagnostic-performance-of-18f-fdg-pet-ct-in-detecting-distant-metastases-in-breast-cancer-27198https://curecurrent.com/trials/a-study-on-the-use-of-fluzoparib-combined-with-chemotherapy-for-neoadjuvant-treatment-of-hrd-positive-hr-her2-breast-can-27199https://curecurrent.com/trials/managed-access-programs-for-lee011-ribociclib-27200https://curecurrent.com/trials/comparison-of-chemotherapy-and-immunotherapy-in-neoadjuvant-therapy-for-tnbc-27201https://curecurrent.com/trials/a-video-intervention-to-improve-patient-understanding-of-tumor-genomic-testing-in-patients-with-metastatic-cancer-27202https://curecurrent.com/trials/telenursing-for-the-early-detection-and-management-of-side-effects-associated-with-cyclin-dependent-kinase-inhibitors-in-27203https://curecurrent.com/trials/neoadjuvant-dpx-survivac-aromatase-inhibition-radiotherapy-or-cyclophosphamide-in-hr-her2-breast-cancer-27204https://curecurrent.com/trials/3-dimensional-conformal-radiation-therapy-or-internal-radiation-therapy-after-breast-conserving-surgery-in-treating-wome-27205https://curecurrent.com/trials/predictive-toxicity-test-linked-to-radiotherapy-after-mastectomy-and-immediate-implant-reconstruction-27206https://curecurrent.com/trials/mass-response-of-tumor-cells-as-a-biomarker-for-rapid-therapy-guidance-traverartgx-27207https://curecurrent.com/trials/ribociclib-for-hr-positive-her2-negative-metastatic-breast-cancer-27208https://curecurrent.com/trials/first-line-palbociclib-and-endocrine-therapy-for-patients-with-hr-her2-advanced-breast-cancer-in-the-real-world-setting-27209https://curecurrent.com/trials/two-different-schedules-of-palbociclib-second-line-endocrine-therapy-in-estrogen-receptor-positive-her2-neg-advanced-met-27210https://curecurrent.com/trials/patient-derived-organoids-to-functionally-characterize-chemotherapy-resistance-in-breast-cancer-27211https://curecurrent.com/trials/biomarker-guided-dual-target-car-t-cells-for-advanced-solid-tumors-27212https://curecurrent.com/trials/fap-pet-ct-for-staging-patients-with-breast-cancer-27213https://curecurrent.com/trials/ruxolitinib-for-premalignant-breast-disease-27214https://curecurrent.com/trials/fulvestrant-and-ipatasertib-for-advanced-her-2-negative-and-estrogen-receptor-positive-er-breast-cancer-following-progre-27215https://curecurrent.com/trials/exercise-training-in-women-with-metastatic-breast-cancer-27216https://curecurrent.com/trials/a-study-of-ly3484356-in-chinese-participants-with-advanced-breast-cancer-27217https://curecurrent.com/trials/evaluation-of-the-medical-benefit-of-spa-therapy-on-fibrosis-after-radiotherapy-for-breast-cancer-or-uadt-upper-aerodige-27218https://curecurrent.com/trials/a-study-of-real-world-treatment-patterns-and-outcomes-among-hr-her2-metastatic-breast-cancer-patients-treated-with-first-27219https://curecurrent.com/trials/nivolumab-ipilimumab-and-bicalutamide-in-human-epidermal-growth-factor-her-2-negative-breast-cancer-patients-27220https://curecurrent.com/trials/neotailor-abiomarker-directed-approach-to-guide-neoadjuvant-therapy-for-patients-with-stage-ii-iii-er-positive-her2-nega-27221https://curecurrent.com/trials/abemaciclib-in-combination-with-bicalutamide-for-androgen-receptor-positive-her2-negative-metastatic-breast-cancer-27222https://curecurrent.com/trials/pooled-analysis-of-patients-with-early-stage-breast-cancer-treated-with-adjuvant-dose-dense-sequential-chemotherapy-a-he-27223https://curecurrent.com/trials/the-relationship-between-gait-parameters-and-balance-disorder-and-fall-risk-in-breast-cancer-related-lymphedema-bcrl-27224https://curecurrent.com/trials/a-phase-i-study-of-tqb3616-on-tolerance-and-pharmacokinetics-27225https://curecurrent.com/trials/avelumab-or-hydroxychloroquine-with-or-without-palbociclib-to-eliminate-dormant-breast-cancer-27226https://curecurrent.com/trials/evaluation-of-tqb3616-capsules-in-a-phase-ii-clinical-trial-for-recurrent-metastatic-breast-cancer-27227https://curecurrent.com/trials/pediatric-reporting-of-adult-onset-genomic-results-27228https://curecurrent.com/trials/phase-ib-trial-of-the-kras-g12c-inhibitor-adagrasib-mrtx849-in-combination-with-the-parp-inhibitor-olaparib-in-patients-27229https://curecurrent.com/trials/a-multicenter-single-arm-phase-ii-exploratory-study-of-eribulin-in-combination-with-anlotinib-for-her2-negative-recurren-27230https://curecurrent.com/trials/artificial-intelligence-and-machine-learning-to-guide-cdk4-6-inhibitor-rechallenge-in-breast-cancer-27231https://curecurrent.com/trials/retrospective-evaluation-of-ultrasound-assisted-tumor-surgery-in-breast-conserving-therapy-27232https://curecurrent.com/trials/sexual-health-and-rehabilitation-for-women-with-metastatic-breast-cancer-share-mc-an-educational-intervention-27233https://curecurrent.com/trials/study-to-evaluate-real-world-effectiveness-with-palbociclib-plus-endocrine-therapy-as-first-line-second-line-treatment-f-27234https://curecurrent.com/trials/a-phase-iii-study-of-kn026-in-combination-with-hb1801-as-adjuvant-therapy-for-resectable-her2-positive-breast-cancer-27235https://curecurrent.com/trials/cisplatin-with-or-without-veliparib-in-treating-patients-with-recurrent-or-metastatic-triple-negative-and-or-brca-mutati-27236https://curecurrent.com/trials/plant-based-nutrition-for-breast-or-endometrial-cancer-27237https://curecurrent.com/trials/survivorship-care-plans-and-telehealth-education-for-the-improvement-of-access-to-cancer-survivorship-the-impact-study-27238https://curecurrent.com/trials/cipn-decision-aid-for-the-improvement-of-chemotherapy-decision-making-in-patients-with-breast-cancer-27239https://curecurrent.com/trials/coenzyme-q10-for-neuroprotection-in-paclitaxel-induced-neuropathy-27240https://curecurrent.com/trials/a-study-of-tqb3616-capsules-combined-with-fulvestrant-injection-in-subjects-with-advanced-breast-cancer-27241https://curecurrent.com/trials/tqb3616-capsules-plus-fulvestrant-compared-to-placebo-plus-fulvestrant-in-previously-treated-breast-cancer-in-clinical-t-27242https://curecurrent.com/trials/evolution-of-clinical-and-motivational-constructs-during-the-physical-activity-program-kheops-already-offered-to-patient-27243https://curecurrent.com/trials/a-prospective-registry-study-in-patients-with-unresectable-locally-advanced-or-metastatic-breast-cancer-mbc-27244https://curecurrent.com/trials/study-of-romiplostim-for-chemotherapy-induced-thrombocytopenia-in-adult-subjects-with-non-small-cell-lung-cancer-nsclc-o-27245https://curecurrent.com/trials/phase-i-study-of-sys6043-in-patients-with-advanced-metastatic-solid-tumors-27246https://curecurrent.com/trials/maximizing-energy-and-reducing-fatigue-in-breast-cancer-survivors-27247https://curecurrent.com/trials/a-pilot-study-of-acupuncture-for-chemotherapy-induced-peripheral-neuropathy-in-breast-cancer-patients-27248https://curecurrent.com/trials/sdm-possible-a-breast-cancer-treatment-decision-aid-for-women-70-with-low-risk-stage-i-breast-cancers-27249https://curecurrent.com/trials/evaluation-of-safety-and-performance-of-intraoperative-detection-of-light-signals-during-electrosurgical-breast-cancer-r-27250https://curecurrent.com/trials/impact-of-the-arm-technique-on-the-prevention-of-lymphedema-after-axillary-lymphadenectomy-a-multicenter-randomized-clin-27251https://curecurrent.com/trials/concept-verification-clinical-trial-on-the-inhibition-of-breast-cancer-lung-metastasis-progression-by-hyperbaric-oxygen-27252https://curecurrent.com/trials/making-informed-choices-on-incorporating-chemoprevention-into-care-michoice-27253https://curecurrent.com/trials/germline-alterations-of-tumor-susceptibility-genes-in-new-york-cancer-patients-27254https://curecurrent.com/trials/a-clinical-study-of-hetrombopag-olamine-tablets-for-thrombocytopenia-induced-by-anti-tumor-treatment-in-advanced-breast-27255https://curecurrent.com/trials/myeloid-derived-suppressor-cell-function-in-breast-cancer-patients-27256https://curecurrent.com/trials/comparing-single-vs-multiple-dose-radiation-for-cancer-patients-with-brain-metastasis-and-receiving-immunotherapy-27257https://curecurrent.com/trials/a-vaccine-stemvac-with-standard-endocrine-based-therapy-or-chemotherapy-for-the-treatment-of-metastatic-hormone-receptor-27258https://curecurrent.com/trials/study-of-sacituzumab-govitecan-hziy-versus-treatment-of-physician-s-choice-in-patients-with-previously-untreated-locally-27259https://curecurrent.com/trials/a-study-of-mov18-ige-in-patients-with-solid-tumours-that-express-folate-receptor-alpha-27260https://curecurrent.com/trials/losartan-in-prevention-of-radiation-induced-heart-failure-27261https://curecurrent.com/trials/perioperative-individually-tailored-psychological-intervention-in-breast-cancer-surgery-27262https://curecurrent.com/trials/inspiratory-muscle-training-for-breast-cancer-patients-on-chemotherapy-27263https://curecurrent.com/trials/a-pilot-study-of-tomographic-optical-breast-imaging-dbt-tobi-to-monitor-response-to-neoadjuvant-therapy-27264https://curecurrent.com/trials/dual-target-car-nk-cells-for-advanced-breast-cancer-her2-tnbc-27265https://curecurrent.com/trials/comparing-the-tdtp-recist-with-recist-1-1-and-other-volumetric-evaluation-methods-for-assessing-the-therapeutic-efficacy-27266https://curecurrent.com/trials/a-study-of-db-1310-in-advanced-metastatic-solid-tumors-27267https://curecurrent.com/trials/the-aus-predict-registry-for-dcis-patients-with-dcisionrt-testing-27268https://curecurrent.com/trials/pembrolizumab-in-treating-participants-with-metastatic-recurrent-or-locally-advanced-cancer-and-genomic-instability-27269https://curecurrent.com/trials/qlc5513-alone-or-in-combination-with-ql1706-in-previously-treated-advanced-or-metastatic-tnbc-27270https://curecurrent.com/trials/dose-escalation-and-dose-expansion-study-of-cpo-100-in-patients-with-advanced-solid-tumors-27271https://curecurrent.com/trials/omega-3-fatty-acids-and-erpr-her2-breast-cancer-prevention-27272https://curecurrent.com/trials/observational-study-of-gut-microbiota-in-abemaciclib-treated-patients-with-and-without-diarrhea-27273https://curecurrent.com/trials/margin-optimisation-using-z-axis-assessment-with-real-time-tomosynthesis-mozart-study-27274https://curecurrent.com/trials/a-study-of-hrs-6208-in-combination-with-hrs-8080-or-fulvestrant-or-letrozole-with-or-without-hrs-6209-in-patients-with-a-27275https://curecurrent.com/trials/diep-flap-breast-reconstruction-perioperative-biomarkers-and-outcomes-27276https://curecurrent.com/trials/a-study-to-describe-treatment-patterns-of-advanced-breast-cancer-in-poland-in-the-real-world-data-setting-27277https://curecurrent.com/trials/a-study-to-learn-about-how-the-study-medicines-called-itraconazole-and-probenecid-change-how-the-body-processes-pf-07220-27278https://curecurrent.com/trials/topical-diclofenac-for-prevention-of-radiation-induced-dermatitis-27279https://curecurrent.com/trials/handheld-ultrasound-device-to-triage-women-with-a-positive-clinical-breast-examination-by-trained-non-radiologists-27280https://curecurrent.com/trials/trop2-targeting-nir-ii-molecular-probe-for-breast-cancer-precise-surgery-27281https://curecurrent.com/trials/same-day-awake-mastectomy-with-immediate-breast-reconstruction-for-patients-with-breast-cancer-27282https://curecurrent.com/trials/9-ing-41-in-patients-with-advanced-cancers-27283https://curecurrent.com/trials/endoscopic-nipple-sparing-mastectomy-through-a-single-axillary-incision-in-breast-cancer-27284https://curecurrent.com/trials/tumor-treating-fields-for-the-treatment-of-leptomeningeal-metastases-of-the-spine-in-patients-with-breast-or-lung-cancer-27285https://curecurrent.com/trials/s1703-serum-tumor-marker-directed-disease-monitoring-in-patients-with-hormone-receptor-positive-her2-negative-metastatic-27286https://curecurrent.com/trials/this-is-a-phase-1-trial-of-zm008-an-anti-llt1-antibody-used-as-single-agent-followed-by-combination-treatment-with-torip-27287https://curecurrent.com/trials/a-study-of-imlunestrant-versus-standard-endocrine-therapy-in-participants-with-early-breast-cancer-27288https://curecurrent.com/trials/study-to-evaluate-efficacy-safety-of-afuresertib-plus-fulvestrant-in-patients-with-locally-advanced-or-metastatic-hr-her-27289https://curecurrent.com/trials/contrast-enhanced-ultrasound-scan-for-the-estimation-of-tissue-pressure-in-patients-with-breast-cancer-27290https://curecurrent.com/trials/mammography-screening-with-artificial-intelligence-masai-27291https://curecurrent.com/trials/the-efficacy-and-safety-of-sintilimab-plus-anlotinib-combined-with-chemotherapy-as-neoadjuvant-therapy-in-tnbc-27292https://curecurrent.com/trials/real-world-treatment-pattern-and-clinical-outcome-with-influential-factors-of-hr-her2-abc-1l-patients-in-china-27293https://curecurrent.com/trials/trastuzumab-deruxtecan-in-first-line-her2-positive-locally-advanced-mbc-patients-resistant-to-trastuzumab-pertuzumab-27294https://curecurrent.com/trials/a-study-to-investigate-the-efficacy-and-safety-of-letrozole-sie-compared-with-femara-both-combined-with-the-cdk4-6-inhib-27295https://curecurrent.com/trials/screening-mammography-single-reading-by-one-radiologist-with-ai-vs-double-reading-by-two-radiologists-ai-bcsq-27296https://curecurrent.com/trials/monitoring-symptoms-to-help-young-women-take-hormone-therapy-for-stage-i-iii-breast-cancer-aspen-study-27297https://curecurrent.com/trials/dalpiciclib-with-or-without-entinostat-and-letrozole-in-hr-her2-early-breast-cancer-27298https://curecurrent.com/trials/cancer-genetic-testing-in-ethnic-populations-27299https://curecurrent.com/trials/a-study-to-prevent-and-improve-sexual-health-concerns-for-people-with-breast-cancer-27300https://curecurrent.com/trials/evaluate-cardiac-function-using-cardiac-mri-and-dosimetric-correlation-27301https://curecurrent.com/trials/effect-of-aerobic-exercises-on-trace-elements-in-post-menopausal-women-after-radiotherapy-27302https://curecurrent.com/trials/classification-of-breast-masses-based-on-visco-elastic-properties-using-save-method-27303https://curecurrent.com/trials/oral-paclitaxel-trial-in-recurrent-and-metastatic-breast-cancer-as-1st-line-therapy-27304https://curecurrent.com/trials/evaluation-of-envisio-smartclip-for-intraoperative-localization-of-breast-masses-27305https://curecurrent.com/trials/til-driven-de-escalated-chemotherapy-in-stage-i-ii-tnbc-27306https://curecurrent.com/trials/study-of-shr-a1811-in-her2-expression-advanced-breast-cancer-with-brain-metastases-27307https://curecurrent.com/trials/epidemiology-and-treatment-of-hr-her2-breast-cancer-in-england-27308https://curecurrent.com/trials/collecting-patient-reported-experiences-with-radiation-dermatitis-in-breast-cancer-patients-undergoing-radiotherapy-27309https://curecurrent.com/trials/a-prospective-non-interventional-study-to-evaluate-clinical-outcomes-of-ribociclib-combined-with-endocrine-therapy-in-el-27310https://curecurrent.com/trials/development-and-usability-evaluation-of-a-knowledge-graph-based-symptom-management-system-for-patients-with-breast-cance-27311https://curecurrent.com/trials/clinical-breast-examination-and-patient-navigation-intervention-in-sub-saharan-africa-27312https://curecurrent.com/trials/investigation-of-the-effects-of-complex-decongestive-physiotherapy-on-sleep-quality-and-quality-of-life-in-women-with-br-27313https://curecurrent.com/trials/motivating-to-exercise-and-diet-and-educating-to-healthy-behaviors-after-breast-cancer-27314https://curecurrent.com/trials/personalized-antiemetic-regimen-according-to-patients-pharmacogenetic-profile-27315https://curecurrent.com/trials/pure-florid-and-pleomorphic-lobular-carcinoma-in-situ-of-the-breast-towards-an-increasingly-uniform-management-27316https://curecurrent.com/trials/open-label-study-to-evaluate-the-safety-tolerability-pk-and-efficacy-of-inx-315-in-patients-with-advanced-cancer-27317https://curecurrent.com/trials/personalized-dendritic-cell-vaccine-pilot-for-high-risk-tnbc-after-neoadjuvant-therapy-27318https://curecurrent.com/trials/bicalutamide-and-abemaciclib-in-inoperable-or-metastatic-androgen-receptor-positive-triple-negative-breast-cancer-27319https://curecurrent.com/trials/biolosion-combined-standard-neoadjuvant-therapy-to-treat-triple-negative-breast-cancer-27320https://curecurrent.com/trials/scalable-communication-modalities-for-returning-genetic-research-results-27321https://curecurrent.com/trials/rankl-inhibition-and-mammographic-breast-density-27322https://curecurrent.com/trials/her2-pet-imaging-in-her2-low-breast-cancers-27323https://curecurrent.com/trials/deep-learning-for-musculoskeletal-complications-in-breast-cancer-27324https://curecurrent.com/trials/efficacy-and-tolerance-of-an-ovarian-stimulation-protocol-combining-follicle-stimulating-hormone-fsh-and-degarelix-aceta-27325https://curecurrent.com/trials/large-language-models-assist-in-tumor-mdt-27326https://curecurrent.com/trials/survey-cns-a-feasibility-study-of-randomising-women-and-men-with-her2-positive-metastatic-breast-cancer-to-central-nervo-27327https://curecurrent.com/trials/safety-ultrasound-conspicuity-and-migration-of-twinkling-markers-in-patients-with-locally-advanced-breast-cancer-27328https://curecurrent.com/trials/a-prospective-study-of-the-genomic-landscape-of-central-nervous-system-disease-secondary-to-breast-cancer-utilising-cell-27329https://curecurrent.com/trials/preservation-of-fertility-by-ovarian-stimulation-associated-with-tamoxifen-prior-chemotherapy-for-breast-cancer-27330https://curecurrent.com/trials/assessment-of-quality-of-life-and-treatment-times-for-patients-with-invasive-type-breast-cancer-in-martinique-27331https://curecurrent.com/trials/evaluation-of-the-efficacy-of-biobran-rice-bran-arabinoxylan-in-supporting-breast-cancer-chemotherapy-27332https://curecurrent.com/trials/turkey-tail-mushroom-for-treating-post-menopausal-women-with-her2-negative-er-positive-breast-cancer-undergoing-surgery-27333https://curecurrent.com/trials/exercise-post-diagnosis-of-breast-cancer-27334https://curecurrent.com/trials/evaluating-the-association-among-changes-in-gut-microbiome-fatigue-and-chemotherapy-induced-nausea-in-early-stage-breast-27335https://curecurrent.com/trials/prediction-in-silico-of-pathological-response-in-a-prospective-cohort-study-of-early-breast-cancer-patients-27336https://curecurrent.com/trials/swedish-ibrance-registries-insights-siri-27337https://curecurrent.com/trials/detection-and-metabolic-characterization-in-dopa-pet-ct-of-brain-metastases-27338https://curecurrent.com/trials/effectiveness-of-a-multimodal-outpatient-supervised-physical-activity-program-to-improve-tolerance-and-efficacy-of-chemo-27339https://curecurrent.com/trials/effectiveness-of-ai-genetic-counseling-program-vs-in-person-genetic-counseling-in-breast-cancer-27340https://curecurrent.com/trials/cognitive-behavioral-therapy-for-fear-of-cancer-recurrence-in-women-with-brca1-2-gene-27341https://curecurrent.com/trials/a-study-to-evaluate-d-0502-in-subjects-with-er-her2-locally-advanced-or-metastatic-breast-cancer-27342https://curecurrent.com/trials/phase-ib-ii-trial-of-abemaciclib-and-elacestrant-in-patients-with-brain-metastasis-due-to-hr-her2-breast-cancer-27343https://curecurrent.com/trials/circulating-micrornas-and-response-to-neoadjuvant-chemotherapy-in-breast-cancer-27344https://curecurrent.com/trials/survivors-uniting-for-remote-guided-exercise-27345https://curecurrent.com/trials/construction-of-a-benchmark-for-breast-ultrasound-ai-interpretation-and-performance-evaluation-of-multimodal-ai-models-27346https://curecurrent.com/trials/effectiveness-and-safety-of-palbociclib-brand-vs-generic-in-iraqi-stage-iv-breast-cancer-patients-27347https://curecurrent.com/trials/patient-s-choice-in-the-reduction-of-their-treatment-in-women-over-65-year-with-breast-cancer-27348https://curecurrent.com/trials/cohort-evaluation-of-body-fluids-early-detection-of-cancer-in-high-risk-individuals-27349https://curecurrent.com/trials/carboplatin-and-paclitaxel-albumin-stabilized-nanoparticle-formulation-before-surgery-in-treating-patients-with-locally-27350https://curecurrent.com/trials/together-breast-cancer-support-platform-27351https://curecurrent.com/trials/evidence-based-practice-for-the-management-of-musculoskeletal-symptoms-in-breast-cancer-patients-undergoing-endocrine-th-27352https://curecurrent.com/trials/randomized-double-blind-phase-ii-trial-of-baby-exemestane-versus-baby-tamoxifen-in-post-menopausal-women-at-high-risk-fo-27353https://curecurrent.com/trials/virtual-support-platform-hercare-application-for-the-improvement-of-survivorship-among-black-breast-cancer-survivors-27354https://curecurrent.com/trials/axillary-management-in-breast-cancer-patients-with-needle-biopsy-proven-nodal-metastases-after-neoadjuvant-chemotherapy-27355https://curecurrent.com/trials/tavns-for-breast-cancer-pain-and-symptom-management-27356https://curecurrent.com/trials/pembrolizumab-and-stereotactic-radiosurgery-srs-of-selected-brain-metastases-in-breast-cancer-patients-27357https://curecurrent.com/trials/determining-molecular-drivers-of-radiation-dermatitis-27358https://curecurrent.com/trials/breast-cancer-implementation-science-study-with-educational-intervention-27359https://curecurrent.com/trials/a-trial-on-the-use-of-point-of-care-ultrasound-in-the-assessment-of-breast-symptoms-27360https://curecurrent.com/trials/tissue-and-serum-derived-exosomal-micrornas-as-predictors-of-neoadjuvant-chemotherapy-response-in-breast-cancer-27361https://curecurrent.com/trials/whole-exome-sequencing-in-finding-causative-variants-in-germline-dna-samples-from-patients-with-peripheral-neuropathy-re-27362https://curecurrent.com/trials/whole-exome-sequencing-in-finding-causative-variants-in-germline-dna-samples-from-patients-with-congestive-heart-failure-27363https://curecurrent.com/trials/gut-and-intratumoral-microbiome-effect-on-the-neoadjuvant-chemotherapy-induced-immunosurveillance-in-triple-negative-bre-27364https://curecurrent.com/trials/demographics-characteristics-and-outcomes-of-male-breast-cancer-patients-at-methodist-health-system-27365https://curecurrent.com/trials/trastuzumab-deruxtecan-in-first-line-her2-positive-metastatic-breast-cancer-with-proactive-toxicity-management-27366https://curecurrent.com/trials/eortc-quality-of-life-measurement-in-males-with-breast-cancer-27367https://curecurrent.com/trials/letrozole-after-tamoxifen-in-treating-women-with-breast-cancer-27368https://curecurrent.com/trials/enhancing-pain-management-among-patients-diagnosed-with-stage-iii-and-stage-iv-of-breast-cancer-the-power-of-immersive-a-27369https://curecurrent.com/trials/virtual-reality-and-music-in-the-oncology-setting-phase-1-27370https://curecurrent.com/trials/combination-study-of-sv-br-1-gm-with-retifanlimab-27371https://curecurrent.com/trials/whole-exome-sequencing-in-finding-causative-variants-in-germline-dna-samples-from-patients-with-hypertension-receiving-b-27372https://curecurrent.com/trials/deployment-and-clinical-evaluation-of-an-ai-powered-digital-oncology-biomarker-tool-to-guide-treatment-in-tnbc-27373https://curecurrent.com/trials/robustness-evaluation-of-deep-inspiration-breath-hold-dibh-plans-in-internal-mammary-irradiation-27374https://curecurrent.com/trials/personalized-breast-cancer-screening-27375https://curecurrent.com/trials/amh-dynamic-changes-to-predict-ovarian-reserve-in-perimenopausal-breast-cancer-27376https://curecurrent.com/trials/a-study-of-parg-inhibitor-etx-19477-in-patients-with-advanced-solid-malignancies-27377https://curecurrent.com/trials/exemption-of-slnb-after-neoadjuvant-therapy-for-triple-negative-and-her2-positive-breast-cancer-27378https://curecurrent.com/trials/promoting-informed-choice-for-breast-cancer-screening-27379https://curecurrent.com/trials/adherence-to-oral-therapies-in-advanced-breast-and-prostate-cancers-27380https://curecurrent.com/trials/regenerative-collagen-scaffold-for-breast-volume-restoration-after-breast-cancer-excision-27381https://curecurrent.com/trials/avera-cancer-sequencing-and-analytics-protocol-asap-27382https://curecurrent.com/trials/a-study-of-the-use-of-text-message-reminders-to-take-palbociclib-27383https://curecurrent.com/trials/well-being-after-breast-cancer-surgery-27384https://curecurrent.com/trials/scarless-advanced-breast-extended-oncoplasty-the-scarabeo-study-27385https://curecurrent.com/trials/a-clinical-study-of-neoadjuvant-treatment-with-tqb2102-for-injection-for-human-epidermal-growth-factor-receptor-2-her2-p-27386https://curecurrent.com/trials/application-of-chinese-herbal-complementary-and-alternative-medicine-cam-to-improve-human-health-and-to-further-botanica-27387https://curecurrent.com/trials/efficacy-and-safety-of-tinengotinib-tablets-combined-with-fulvestrant-injection-in-patients-with-hr-positive-and-her-2-n-27388https://curecurrent.com/trials/study-of-nanrilkefusp-alfa-alone-and-with-pembrolizumab-in-adult-patients-with-advanced-metastatic-solid-tumors-27389https://curecurrent.com/trials/population-based-germline-testing-for-early-detection-and-prevention-of-cancer-27390https://curecurrent.com/trials/cfi-402257-in-combination-with-paclitaxel-in-patients-with-advanced-metastatic-her2-negative-breast-cancer-27391https://curecurrent.com/trials/prospective-validation-of-ataraxis-ai-test-for-predicting-treatment-response-in-neoadjuvant-breast-cancer-27392https://curecurrent.com/trials/epirubicin-docetaxel-and-pegfilgrastim-in-treating-women-with-locally-advanced-or-inflammatory-breast-cancer-27393https://curecurrent.com/trials/a-study-on-pain-after-breast-reconstruction-27394https://curecurrent.com/trials/prospective-evaluation-of-targeted-axillary-dissection-tad-27395https://curecurrent.com/trials/breast-tumour-size-measurement-by-field-cycling-imaging-27396https://curecurrent.com/trials/photo-acoustic-and-ultrasonographic-mammoscope-27397https://curecurrent.com/trials/precise-treatment-for-blis-subtype-of-tnbc-in-the-first-line-treatment-of-locally-advanced-or-metastatic-breast-cancer-27398https://curecurrent.com/trials/study-of-monochromatic-x-ray-mammography-system-27399https://curecurrent.com/trials/screening-for-brain-metastases-27400https://curecurrent.com/trials/optimizing-functional-recovery-after-breast-cancer-treatment-27401https://curecurrent.com/trials/breast-cancer-study-tracking-risk-awareness-of-alcohol-consumption-and-improving-knowledge-in-young-adult-women-27402https://curecurrent.com/trials/integrated-testing-strategy-for-simultaneous-detection-of-esr-1-and-gbrca-mutations-via-liquid-biopsy-in-hr-her2-metasta-27403https://curecurrent.com/trials/wide-angle-tomosynthesis-and-ai-in-diagnostic-mammography-27404https://curecurrent.com/trials/pik3ca-mutational-status-assessment-27405https://curecurrent.com/trials/robotic-nipple-sparing-mastectomy-vs-conventional-open-technique-27406https://curecurrent.com/trials/homologous-recombination-repair-status-as-a-biomarker-of-response-in-locally-recurrent-metastatic-triple-negative-breast-27407https://curecurrent.com/trials/analysis-of-circulating-tumor-dna-ctdna-in-her2-low-advanced-metastatic-breast-cancer-27408https://curecurrent.com/trials/ctdna-in-her2-ebc-neoadjuvant-treatment-27409https://curecurrent.com/trials/a-single-arm-single-center-phase-ii-clinical-study-of-camrelizumab-combined-with-radiochemotherapy-as-neoadjuvant-therap-27410https://curecurrent.com/trials/cryo-1-cryoablation-in-elderly-patients-with-early-stage-breast-cancer-27411https://curecurrent.com/trials/phase-ii-study-of-hlx43-monotherapy-or-combined-with-immune-checkpoint-inhibitors-in-patients-with-locally-advanced-recu-27412https://curecurrent.com/trials/conventional-therapy-vs-telerehabilitation-with-trak-in-patients-undergoing-axillary-lymph-node-removal-27413https://curecurrent.com/trials/longitudinal-impact-of-adjuvant-chemotherapy-on-functional-status-comorbidity-and-quality-of-life-27414https://curecurrent.com/trials/hypofractionated-radiation-therapy-vs-standard-treatment-in-breast-cancer-27415https://curecurrent.com/trials/a-study-of-samuraciclib-and-elacestrant-in-participants-with-metastatic-or-locally-advanced-hr-her2-negative-breast-canc-27416https://curecurrent.com/trials/a-study-of-tucatinib-plus-trastuzumab-deruxtecan-in-her2-breast-cancer-27417https://curecurrent.com/trials/a-study-of-t-dxd-for-the-treatment-of-solid-tumors-harboring-her2-activating-mutations-27418https://curecurrent.com/trials/clinical-and-pharmacoeconomic-assessment-of-cdk4-6-inhibitors-for-treatment-of-breast-cancer-in-egypt-27419https://curecurrent.com/trials/dual-target-car-nk-cells-for-advanced-breast-cancer-her2-and-tnbc-27420https://curecurrent.com/trials/accurate-rapid-and-inexpensive-mri-protocol-for-breast-cancer-screening-27421https://curecurrent.com/trials/correlation-between-tils-and-blood-cell-counts-in-triple-negative-breast-cancer-patients-27422https://curecurrent.com/trials/metabolic-flexibility-in-patients-with-early-triple-negative-breast-cancer-27423https://curecurrent.com/trials/study-on-the-level-of-physical-activity-in-patients-diagnosed-with-breast-cancer-in-spain-27424https://curecurrent.com/trials/pembrolizumab-adjuvant-in-patients-with-early-stage-triple-negative-breast-cancer-with-residual-disease-after-neoadjuvan-27425https://curecurrent.com/trials/accelerated-partial-breast-irradiation-following-lumpectomy-for-breast-cancer-27426https://curecurrent.com/trials/effect-of-helmet-type-home-use-low-level-light-therapy-device-for-chemotherapy-induced-alopecia-27427https://curecurrent.com/trials/the-real-world-study-of-pyrotinib-in-the-treatment-of-advanced-breast-cancer-with-her2-positive-27428https://curecurrent.com/trials/blood-brain-barrier-disruption-bbbd-using-mrgfus-in-the-treatment-of-her2-positive-breast-cancer-brain-metastases-27429https://curecurrent.com/trials/study-of-tucatinib-and-doxil-in-participants-with-human-epidermal-growth-factor-receptor-2-positive-her2-metastatic-brea-27430https://curecurrent.com/trials/hypofractionated-online-adaptive-radiotherapy-of-breast-cancer-27431https://curecurrent.com/trials/predicting-recurrence-in-hr-her2-early-breast-cancer-27432https://curecurrent.com/trials/a-study-to-evaluate-hlx22-in-combination-with-hlx87-in-patients-with-her2-positive-recurrent-or-metastatic-breast-cancer-27433https://curecurrent.com/trials/dextrose-hydrodissection-for-post-breast-cancer-chest-wall-and-axillary-tightness-27434https://curecurrent.com/trials/shoulder-exercise-training-on-pain-range-of-motion-and-functional-limitations-in-women-following-unilateral-mastectomy-27435https://curecurrent.com/trials/trial-of-superiority-of-stereotactic-body-radiation-therapy-in-patients-with-breast-cancer-27436https://curecurrent.com/trials/prevention-of-sequelae-pain-after-breast-cancer-surgery-by-self-massages-and-self-stretching-impact-of-learning-workshop-27437https://curecurrent.com/trials/ablation-compare-with-surgery-for-early-breast-cancer-27438https://curecurrent.com/trials/xenografts-development-from-surgical-tumor-samples-of-patients-with-triple-negative-or-luminal-b-breast-cancer-27439https://curecurrent.com/trials/receptive-music-therapy-effects-on-anxiety-depression-qol-and-egf-il-8-and-nfl-during-the-breast-cancer-treatment-27440https://curecurrent.com/trials/a-randomized-controlled-trial-of-acupuncture-for-the-management-of-hot-flashes-in-patients-with-hormone-receptor-positiv-27441https://curecurrent.com/trials/preoperative-window-opportunity-study-with-giredestrant-or-tamoxifen-in-premenopausal-women-with-er-her2-ki67-10-27442https://curecurrent.com/trials/screening-contrast-enhanced-mammography-27443https://curecurrent.com/trials/angiomammography-and-neoadjuvant-chemotherapy-27444https://curecurrent.com/trials/effect-of-acupuncture-on-psychoneurological-symptom-cluster-in-breast-cancer-survivors-27445https://curecurrent.com/trials/living-well-with-advanced-breast-cancer-27446https://curecurrent.com/trials/establishment-of-an-ex-vivo-tumor-collection-of-triple-negative-breast-cancers-in-order-to-validate-the-interest-of-inno-27447https://curecurrent.com/trials/cryoablation-versus-lumpectomy-in-early-stage-breast-cancer-27448https://curecurrent.com/trials/intensity-modulated-radiation-therapy-or-3-dimensional-conformal-radiation-therapy-in-treating-patients-with-lymph-node-27449https://curecurrent.com/trials/leflunomide-in-previously-treated-metastatic-triple-negative-cancers-27450https://curecurrent.com/trials/ml-score-prediction-of-cardiotoxicity-in-cancer-patients-receiving-anthracycline-chemotherapy-or-her2-targeted-therapies-27451https://curecurrent.com/trials/study-of-blood-samples-in-patients-with-breast-cancer-27452https://curecurrent.com/trials/feasibility-of-exosome-analysis-in-cerebrospinal-fluid-during-the-diagnostic-workup-of-metastatic-meningitis-27453https://curecurrent.com/trials/psychosocial-support-to-facilitate-the-return-to-employment-of-women-with-breast-cancer-27454https://curecurrent.com/trials/moving-on-after-breast-cancer-trial-for-depressed-breast-cancer-survivors-in-pakistan-27455https://curecurrent.com/trials/a-study-to-learn-about-a-new-medicine-called-vepdegestrant-arv-471-pf-07850327-in-people-who-have-advanced-metastatic-br-27456https://curecurrent.com/trials/app-for-adverse-events-to-oral-chemotherapy-pilot-study-27457https://curecurrent.com/trials/research-and-analysis-of-the-mechanisms-involved-in-the-emergence-of-breast-cancer-stem-cells-reprim-27458https://curecurrent.com/trials/intraoperative-radiation-therapy-in-treating-patients-with-breast-cancer-undergoing-breast-conserving-surgery-27459https://curecurrent.com/trials/a-study-for-ctc-expression-and-cfdna-rna-assessment-in-metastatic-breast-cancer-patients-27460https://curecurrent.com/trials/follow-up-of-sequential-chemotherapy-and-stimulation-for-fertility-preservation-in-young-patients-with-breast-cancer-27461https://curecurrent.com/trials/access-to-genetic-testing-in-underserved-patients-with-cancer-27462https://curecurrent.com/trials/impact-of-personalized-and-remote-support-centered-on-exercise-and-physical-activity-for-breast-cancer-patients-27463https://curecurrent.com/trials/impact-of-emotional-skills-of-young-women-and-their-partner-on-adjustment-to-cancer-27464https://curecurrent.com/trials/microbiome-and-association-with-implant-infections-27465https://curecurrent.com/trials/study-to-determine-the-antitumor-activity-of-new-car-macrophages-in-breast-cancer-patients-derived-organoids-27466https://curecurrent.com/trials/efficacy-and-safety-of-vaginal-radiofrequency-for-vulvovaginal-atrophy-in-breast-cancer-patients-27467https://curecurrent.com/trials/evaluation-of-carebot-ai-mmg-medical-device-for-breast-lesion-detection-and-density-assessment-27468https://curecurrent.com/trials/bintrafusp-alfa-and-pimasertib-for-the-treatment-of-patients-with-brain-metastases-27469https://curecurrent.com/trials/mechanical-stimulation-on-pain-level-and-functional-discomfort-after-breast-cancer-surgery-27470https://curecurrent.com/trials/risk-of-infertility-related-to-adjuvant-chemotherapy-for-early-breast-cancer-oocyte-embryo-cryopreservation-27471https://curecurrent.com/trials/tumor-margin-skin-tattooing-before-neo-adjuvant-chemotherapy-in-patients-with-breast-cancer-27472https://curecurrent.com/trials/study-of-df1001-in-patients-with-advanced-solid-tumors-27473https://curecurrent.com/trials/eribulin-mesylate-based-therapy-in-patients-with-advanced-her2-negative-breast-cancer-previously-treated-with-adc-27474https://curecurrent.com/trials/radical-fimbriectomy-for-young-brca-mutation-carriers-27475https://curecurrent.com/trials/impower-qol-impact-of-discontinuing-premedication-for-weekly-paclitaxel-on-breast-cancer-patient-s-quality-of-life-27476https://curecurrent.com/trials/gene-modified-immune-cells-after-conditioning-regimen-for-the-treatment-of-stage-iiic-or-iv-melanoma-or-metastatic-solid-27477https://curecurrent.com/trials/early-detection-of-metastatic-recurrence-among-patients-with-stage-ii-or-iii-triple-negative-breast-cancer-using-liquid-27478https://curecurrent.com/trials/preoperative-single-fraction-radiotherapy-in-early-stage-breast-cancer-27479https://curecurrent.com/trials/act-mbc-a-study-of-circulating-tumor-cells-ctcs-in-metastatic-breast-cancer-mbc-27480https://curecurrent.com/trials/multigene-risk-score-combined-with-ki-67-dynamic-assessment-in-stratified-neoadjuvant-endocrine-therapy-treatment-with-o-27481https://curecurrent.com/trials/early-phase-study-of-kesonotide-in-participants-with-solid-tumours-27482https://curecurrent.com/trials/a-dose-randomization-study-of-bulumtatug-fuvedotin-in-tnbc-patients-previously-treated-with-adcs-27483https://curecurrent.com/trials/a-single-arm-interventional-trial-of-pepper-robot-delivered-cancer-education-for-adults-with-intellectual-disability-27484https://curecurrent.com/trials/influencing-factors-and-mechanisms-of-capsular-contracture-after-prosthesis-reconstruction-in-patients-with-breast-cance-27485https://curecurrent.com/trials/fluzoparib-in-combination-with-or-without-camrelizumab-for-homologous-recombinant-deficiency-hrd-her2-negative-advanced-27486https://curecurrent.com/trials/breast-reconstruction-and-body-map-assessment-by-functional-mri-remasco-27487https://curecurrent.com/trials/feasibility-evaluation-of-the-muse-magnetic-resonance-guided-focused-ultrasound-system-27488https://curecurrent.com/trials/letrozole-anastrozole-exemestane-or-tamoxifen-citrate-in-treating-postmenopausal-women-with-breast-cancer-27489https://curecurrent.com/trials/exploring-inflammation-and-social-determinants-study-in-breast-cancer-patients-27490https://curecurrent.com/trials/the-effect-of-pain-neuroscience-education-and-behavioural-graded-activity-on-chronic-pain-in-breast-cancer-survivors-27491https://curecurrent.com/trials/psychometric-validation-quality-of-life-scale-in-young-women-with-a-non-metastatic-breast-cancer-and-her-partner-27492https://curecurrent.com/trials/ribociclib-real-world-treatment-patterns-and-clinical-outcomes-among-women-with-hr-her2-advanced-or-metastatic-breast-ca-27493https://curecurrent.com/trials/longitudinal-body-composition-assessment-in-breast-cancer-patients-27494https://curecurrent.com/trials/predicting-olaparib-sensitivity-in-patients-with-unresectable-locally-advanced-metastatic-her2-negative-breast-cancer-27495https://curecurrent.com/trials/engage-psychosocial-intervention-for-cancer-symptoms-27496https://curecurrent.com/trials/pas-1ml-magtrace-for-sentinel-lymph-node-biopsy-in-breast-cancer-patients-27497https://curecurrent.com/trials/the-efficacy-and-safety-of-trastuzumab-rezetecan-shr-a1811-in-her2-low-unresectable-metastatic-breast-cancer-patients-wi-27498https://curecurrent.com/trials/imaging-evaluation-of-the-therapeutic-response-of-breast-cancer-bone-metastasis-emos-27499https://curecurrent.com/trials/lidocaine-iv-injection-with-different-doses-for-patients-with-neuropathic-pain-after-mastectomy-27500https://curecurrent.com/trials/a-novel-approach-in-the-evaluation-of-breast-masses-with-doppler-us-27501https://curecurrent.com/trials/improving-breast-cancer-screening-uptake-through-tailored-reminder-letters-27502https://curecurrent.com/trials/a-study-of-mk-4700-alone-or-with-pembrolizumab-in-participants-with-advanced-or-metastatic-solid-tumors-mk-4700-001-27503https://curecurrent.com/trials/clinical-trial-of-alpelisb-and-tucatinib-in-patients-with-pik3ca-mutant-her2-metastatic-breast-cancer-27504https://curecurrent.com/trials/alrn-6924-and-paclitaxel-in-treating-patients-with-advanced-metastatic-or-unresectable-solid-tumors-27505https://curecurrent.com/trials/a-innovative-web-based-dance-movement-therapy-27506https://curecurrent.com/trials/the-effect-of-mindfulness-based-breathing-exercises-on-symptom-control-27507https://curecurrent.com/trials/ipatasertib-pertuzumab-trastuzumab-in-advanced-her2-pi3kca-mutant-breast-cancer-patients-27508https://curecurrent.com/trials/olaparib-in-combination-with-vorinostat-in-patients-with-relapsed-refractory-and-or-metastatic-breast-cancer-27509https://curecurrent.com/trials/a-study-of-ak117-ak112-in-metastatic-triple-negative-breast-cancer-27510https://curecurrent.com/trials/letrozole-in-post-menopausal-patients-with-operable-hormone-sensitive-breast-cancer-27511https://curecurrent.com/trials/ak112-or-placebo-plus-nab-paclitaxel-as-first-line-treatment-in-inoperable-locally-advanced-metastatic-triple-negative-b-27512https://curecurrent.com/trials/pyrotinib-combined-with-trastuzumab-and-pertuzumab-for-maintenance-therapy-in-her2-positive-advanced-breast-cancer-27513https://curecurrent.com/trials/meditation-for-chemotherapy-induced-nausea-and-vomiting-in-women-with-breast-cancer-27514https://curecurrent.com/trials/plyometric-strength-endurance-exercise-in-breast-cancer-27515https://curecurrent.com/trials/benefit-of-mechanical-ischemic-preconditioning-on-tolerance-of-adipose-tissue-to-ischemia-reperfusion-of-type-diep-deep-27516https://curecurrent.com/trials/impact-of-sequential-chemotherapy-on-young-patients-breast-cancer-treated-fertility-27517https://curecurrent.com/trials/development-and-assessment-of-the-8-item-chronic-pain-acceptance-questionnaire-to-measure-disease-acceptance-in-women-wi-27518https://curecurrent.com/trials/breast-cancer-and-quality-of-life-27519https://curecurrent.com/trials/molecular-pd-l1-pet-ct-imaging-with-89zr-atezolizumab-in-metastatic-triple-negative-breast-cancer-27520https://curecurrent.com/trials/level-i-ii-axillary-irradiation-in-breast-cancer-with-sentinel-node-macro-metastases-27521https://curecurrent.com/trials/lynparza-breast-cancer-in-the-adjuvant-setting-japan-post-marketing-surveillance-pms-27522https://curecurrent.com/trials/pulsed-electromagnetic-fields-pemfs-a-highly-selective-breast-cancer-treatment-platform-pascal-27523https://curecurrent.com/trials/study-on-using-trop2-pet-and-18f-fdg-pet-to-predict-the-efficacy-of-anti-trop2-adc-treatment-in-advanced-breast-cancer-27524https://curecurrent.com/trials/a-study-of-biological-genetic-and-constitutional-factors-and-non-invasive-monitoring-to-assess-personal-cancer-risks-27525https://curecurrent.com/trials/rna-immunotherapy-of-ivac-w-bre1-uid-and-ivac-m-uid-27526https://curecurrent.com/trials/healthy-eating-and-active-lifestyle-heal-breast-cancer-program-outcomes-27527https://curecurrent.com/trials/feasibility-study-of-cbct-for-igrt-in-cancer-patients-27528https://curecurrent.com/trials/real-life-evaluation-of-endopredict-in-early-hr-her2-breast-cancer-27529https://curecurrent.com/trials/mobile-app-supported-hpv-and-breast-cancer-awareness-program-27530https://curecurrent.com/trials/camrelizumab-plus-risedronate-and-chemotherapy-for-triple-negative-breast-cancer-an-exploratory-clinical-study-on-mechan-27531https://curecurrent.com/trials/efficacy-and-safety-of-the-proposed-biosimilar-pertuzumab-pert-ijs-versus-eu-perjeta-along-with-trastuzumab-and-chemothe-27532https://curecurrent.com/trials/evaluation-of-clinical-efficacy-of-augmented-reality-ar-based-breast-cancer-medical-imaging-solution-skia-breast-localiz-27533https://curecurrent.com/trials/dalpiciclib-combined-with-endocrine-therapy-and-metronomic-capecitabine-vs-dalpiciclib-combined-with-endocrine-therapy-f-27534https://curecurrent.com/trials/facility-based-multi-modal-rehab-vs-home-based-resistance-exercise-for-quality-of-life-in-breast-cancer-survivors-27535https://curecurrent.com/trials/sahara-04-adaptive-radiotherapy-in-hypersensitive-patients-and-high-locoregional-risk-breast-cancer-with-ethos-technolog-27536https://curecurrent.com/trials/study-of-vitamin-d-supplementation-tailored-to-vitamin-d-deficiency-in-breast-cancer-patients-27537https://curecurrent.com/trials/impact-of-supplementation-with-synbiotics-and-prebiotics-on-cognitive-decline-associated-with-neoadjuvant-chemotherapy-i-27538https://curecurrent.com/trials/immune-checkpoint-inhibitor-response-in-solid-tumors-using-a-live-tumor-diagnostic-platform-27539https://curecurrent.com/trials/her2-low-unresectable-and-or-metastatic-breast-cancer-in-russia-27540https://curecurrent.com/trials/anti-tumor-effect-of-ixabepilone-in-metastatic-breast-cancer-mbc-selected-by-the-ixabepilone-drp-27541https://curecurrent.com/trials/personalization-of-breast-radiotherapy-according-to-loco-regional-recurrence-risk-and-toxicity-probability-27542https://curecurrent.com/trials/a-validation-study-to-determine-concordance-of-liquid-biopsy-and-breast-cancer-diagnosis-27543https://curecurrent.com/trials/neoadjuvant-study-chemotherapy-vs-letrozole-abemaciclib-in-hr-her2-high-intermediate-risk-breast-cancer-patients-27544https://curecurrent.com/trials/study-in-leptomeningeal-metastases-of-breast-cancer-27545https://curecurrent.com/trials/serplulimab-combined-with-trastuzumab-rezetecan-as-neoadjuvant-therapy-for-triple-negative-breast-cancer-27546https://curecurrent.com/trials/study-of-multi-mode-thermal-therapy-combined-with-immunotherapy-in-patients-with-her2-negative-breast-cancer-with-liver-27547https://curecurrent.com/trials/feasibility-of-serial-multisite-image-guided-biopsy-to-study-breast-cancer-evolution-27548https://curecurrent.com/trials/safety-and-pharmacokinetics-of-tucatinib-mk-7119-in-chinese-participants-with-cancer-mk-7119-002-27549https://curecurrent.com/trials/exploratory-study-therapeutic-fasting-reduce-physical-limitations-quality-of-life-during-aromatase-inhibitor-therapy-27550https://curecurrent.com/trials/assessing-the-changes-in-markers-of-calcium-vitamin-metabolism-of-for-breast-cancer-adjuvant-calciobs-27551https://curecurrent.com/trials/long-term-follow-up-of-the-tam-01-study-and-pooled-analysis-of-low-dose-tamoxifen-studies-in-non-invasive-or-microinvasi-27552https://curecurrent.com/trials/compression-therapy-of-hands-and-feet-for-the-prevention-of-taxane-or-oxaliplatin-induced-peripheral-neuropathy-27553https://curecurrent.com/trials/letrozole-plus-ribociclib-or-placebo-as-neo-adjuvant-therapy-in-er-positive-her2-negative-early-breast-cancer-27554https://curecurrent.com/trials/a-study-to-evaluate-the-intratumoral-influenza-vaccine-administration-in-patients-with-breast-cancer-27555https://curecurrent.com/trials/role-of-pro-resolving-lipid-mediators-in-obesity-associated-diseases-27556https://curecurrent.com/trials/long-term-follow-up-in-women-with-early-breast-cancer-three-years-of-more-post-primary-treatment-27557https://curecurrent.com/trials/anastrazole-fulvestrant-abemaciclib-for-hr-her2-metastatic-breast-cancer-27558https://curecurrent.com/trials/clinical-validation-of-early-detection-blood-test-for-universal-large-scale-breast-cancer-screening-27559https://curecurrent.com/trials/breathwork-app-for-cancer-survivors-27560https://curecurrent.com/trials/effects-of-neoadjuvant-prehabilitation-on-post-interventional-physical-and-psychological-outcomes-in-oncology-patients-w-27561https://curecurrent.com/trials/pik3ca-pten-altered-advanced-breast-cancer-treated-with-men1611-monotherapy-or-in-combination-with-eribulin-27562https://curecurrent.com/trials/a-dose-finding-phase-1-of-sarilumab-plus-capecitabine-in-her2-neu-negative-metastatic-breast-cancer-and-a-single-arm-his-27563https://curecurrent.com/trials/a-phase-ii-study-to-evaluate-the-efficacy-and-safety-of-hlx43-in-patients-with-hormone-receptor-positive-her2-negative-l-27564https://curecurrent.com/trials/breastvax-radiation-boost-to-enhance-immune-checkpoint-blockade-therapy-27565https://curecurrent.com/trials/a-pilot-study-of-total-body-pet-using-fda-approved-radiotracers-beyond-18f-fdg-27566https://curecurrent.com/trials/application-of-vasculens-2-0-a-mixed-reality-system-for-surgical-guidance-during-diep-flap-harvest-27567https://curecurrent.com/trials/care-cancer-risk-perception-and-women-of-color-27568https://curecurrent.com/trials/assessment-of-sensory-gating-attention-and-executive-control-in-breast-cancer-27569https://curecurrent.com/trials/talimogene-laherparepvec-in-combination-with-neoadjuvant-chemotherapy-in-triple-negative-breast-cancer-27570https://curecurrent.com/trials/muscle-loss-and-fatigue-as-a-consequence-of-radiotherapy-27571https://curecurrent.com/trials/effects-of-combined-upper-extremity-exercise-and-pneumatic-compression-therapy-on-breast-cancer-related-lymphedema-27572https://curecurrent.com/trials/empowering-vulnerable-and-resilient-latinas-to-obtain-breast-cancer-care-27573https://curecurrent.com/trials/topical-or-oral-minoxidil-for-the-treatment-of-endocrine-therapy-induced-alopecia-in-patients-with-stage-i-iv-breast-can-27574https://curecurrent.com/trials/using-diagnostic-tools-to-stage-breast-cancer-27575https://curecurrent.com/trials/partial-breast-re-irradiation-for-breast-cancer-27576https://curecurrent.com/trials/effect-of-transcutaneous-auricular-vagus-nerve-stimulation-on-perioperative-negative-emotions-in-breast-cancer-surgery-p-27577https://curecurrent.com/trials/tomosynthesis-vs-contrast-enhanced-mammography-in-women-with-personal-history-of-breast-cancer-in-western-pennsylvania-27578https://curecurrent.com/trials/physiotherapy-in-women-with-peripheral-persistent-pain-following-breast-cancer-treatment-27579https://curecurrent.com/trials/optimising-mammography-screening-accuracy-with-blood-based-biomarkers-27580https://curecurrent.com/trials/peritumoral-and-periganglionic-infiltration-of-levobupivacaine-prior-to-conservative-surgery-for-triple-negative-breast-27581https://curecurrent.com/trials/arx788-in-her2-positive-metastatic-breast-cancer-subjects-ace-breast-03-27582https://curecurrent.com/trials/nt-i7-efineptakin-alfa-in-combination-with-pembrolizumab-in-participants-with-advanced-solid-tumors-27583https://curecurrent.com/trials/acupuncture-for-hot-flashes-in-hormone-receptor-positive-breast-cancer-a-randomized-controlled-trial-27584https://curecurrent.com/trials/effect-of-montelukast-on-doxorubicin-induced-cardiotoxicity-in-breast-cancer-27585https://curecurrent.com/trials/comparing-vacuum-assisted-percutaneous-excision-to-open-surgical-excision-for-borderline-or-high-risk-breast-lesions-27586https://curecurrent.com/trials/study-on-recurrent-breast-cancer-and-repeated-radiation-therapy-27587https://curecurrent.com/trials/tactive-u-a-study-to-learn-about-the-study-medicine-vepdegestrant-when-given-with-other-medicines-in-people-with-advance-27588https://curecurrent.com/trials/humidified-forest-oils-for-immune-system-recovery-in-stage-i-iii-breast-or-prostate-cancer-27589https://curecurrent.com/trials/spectral-cancer-tissue-recognition-i-27590https://curecurrent.com/trials/neoadjuvant-toripalimab-plus-sbrt-for-chemo-resistant-triple-negative-breast-cancer-27591https://curecurrent.com/trials/ehealth-educational-intervention-to-improve-self-management-and-coping-behaviors-among-cancer-patients-27592https://curecurrent.com/trials/long-term-effects-of-breast-cancer-treatment-27593https://curecurrent.com/trials/bioequivalence-study-of-paclitaxel-for-injection-albumin-bound-in-subjects-with-breast-cancer-27594https://curecurrent.com/trials/vaccine-to-prevent-recurrence-in-patients-with-her-2-positive-breast-cancer-27595https://curecurrent.com/trials/partial-irradiation-and-sequential-vs-concurrent-chemo-early-breast-cancer-27596https://curecurrent.com/trials/a-study-on-the-efficacy-and-safety-of-switching-between-two-targeted-strategies-hp-chemotherapy-and-hpy-chemotherapy-aft-27597https://curecurrent.com/trials/automated-breast-radiation-therapy-using-an-mr-guided-process-27598https://curecurrent.com/trials/to-evaluate-the-clinical-efficacy-of-probiotics-in-patients-with-the-breast-cancer-27599https://curecurrent.com/trials/choices-about-genetic-testing-and-learning-your-risk-with-smart-technology-27600https://curecurrent.com/trials/adherence-to-aromatase-inhibitors-abemaciclib-treatment-in-patients-with-early-stage-her2-negative-breast-cancer-27601https://curecurrent.com/trials/pragmatic-study-to-optimize-neoadjuvant-treatment-and-surgical-de-escalation-in-hr-her2-early-breast-cancer-using-oncoty-27602https://curecurrent.com/trials/pilot-observational-study-examining-the-effect-of-endocrine-therapy-on-aging-27603https://curecurrent.com/trials/il-1-inhibition-in-early-tnbc-27604https://curecurrent.com/trials/a-study-evaluating-the-safety-and-efficacy-of-env-101-taladegib-in-patients-with-advanced-solid-tumors-harboring-ptch1-l-27605https://curecurrent.com/trials/solifenacin-compared-to-clonidine-for-reducing-hot-flashes-among-breast-cancer-patients-27606https://curecurrent.com/trials/genetic-risk-estimations-for-influencing-decision-making-in-women-at-high-risk-of-breast-cancer-genre-2-study-27607https://curecurrent.com/trials/a-vaccine-h2nvac-before-surgery-for-the-treatment-of-her2-expressing-ductal-carcinoma-in-situ-27608https://curecurrent.com/trials/carboplatin-and-nab-paclitaxel-with-or-without-vorinostat-in-treating-women-with-newly-diagnosed-operable-breast-cancer-27609https://curecurrent.com/trials/the-person-centered-evolution-of-radiotherapy-services-in-ontario-study-27610https://curecurrent.com/trials/the-momentum-study-the-multiple-outcome-evaluation-of-radiation-therapy-using-the-mr-linac-study-27611https://curecurrent.com/trials/higher-per-daily-treatment-dose-radiation-therapy-or-standard-per-daily-treatment-radiation-therapy-in-treating-patients-27612https://curecurrent.com/trials/pilot-study-of-a-web-based-decision-aid-for-young-women-with-breast-cancer-during-the-proposal-for-preservation-of-ferti-27613https://curecurrent.com/trials/microbiome-immunotherapy-neoadjuvant-assessment-27614https://curecurrent.com/trials/blessed-expanded-access-for-dng64-car-v-for-advanced-pancreatic-cancer-sarcoma-and-carcinoma-of-breast-27615https://curecurrent.com/trials/nature-sounds-as-a-pain-and-anxiety-reducing-strategy-in-patients-undergoing-breast-core-biopsy-27616https://curecurrent.com/trials/longitudinal-sexual-and-reproductive-health-study-of-women-with-breast-cancer-and-lymphoma-27617https://curecurrent.com/trials/tart-cherry-juice-as-a-dietary-supplement-for-the-prevention-of-paclitaxel-induced-neuropathy-27618https://curecurrent.com/trials/tailored-exercise-to-reduce-aromatase-inhibitor-associated-musculoskeletal-symptoms-27619https://curecurrent.com/trials/comparison-of-ipc-therapy-as-an-alternative-or-an-adjunct-to-mld-within-cdt-for-bcrl-27620https://curecurrent.com/trials/study-of-trastuzumab-deruxtecan-t-dxd-vs-investigator-s-choice-chemotherapy-in-her2-low-hormone-receptor-positive-metast-27621https://curecurrent.com/trials/open-label-single-center-single-arm-phase-2-study-of-neoadjuvant-pembrolizumab-in-combination-with-carboplatin-and-pacli-27622https://curecurrent.com/trials/aky15-hk-301-nepa-study-27623https://curecurrent.com/trials/a-study-of-serum-folate-levels-in-patients-treated-with-olaparib-27624https://curecurrent.com/trials/reiki-breast-surgery-qol-project-for-women-undergoing-breast-surgery-27625https://curecurrent.com/trials/the-lysa-linking-you-to-support-and-advice-trial-27626https://curecurrent.com/trials/an-interactive-time-restricted-diet-intervention-txt4fasting-for-reducing-neurocognitive-decline-and-improving-survival-27627https://curecurrent.com/trials/psilocybin-assisted-psychotherapy-in-cancer-patients-with-adjustment-disorder-27628https://curecurrent.com/trials/predicting-response-to-neoadjuvant-endocrine-therapy-neo-predict-27629https://curecurrent.com/trials/testing-the-use-of-fulvestrant-and-binimetinib-targeted-treatment-for-nf1-mutation-in-hormone-receptor-positive-metastat-27630https://curecurrent.com/trials/development-of-patient-derived-xenografts-pdx-in-patients-with-breast-cancer-27631https://curecurrent.com/trials/riluzole-for-preventing-cognitive-dysfunction-in-ca-pts-receiving-chemo-refocus-pilot-trial-27632https://curecurrent.com/trials/predictive-factors-for-cns-metastases-in-early-breast-cancer-using-liquid-biopsy-akra-c-s-27633https://curecurrent.com/trials/fulvestrant-with-or-without-ganetespib-in-hr-breast-cancer-27634https://curecurrent.com/trials/clinical-outcomes-and-complications-in-two-stage-breast-reconstruction-using-microtextured-and-nanotextured-expanders-27635https://curecurrent.com/trials/disitamab-vedotin-plus-bevacizumab-in-her2-low-metastatic-breast-cancer-after-t-dxd-failure-a-phase-ii-study-27636https://curecurrent.com/trials/study-of-oral-mrt-2359-in-selected-cancer-patients-27637https://curecurrent.com/trials/study-on-the-safety-and-tolerability-of-postoperative-radiotherapy-concurrent-with-cdk4-6-inhibitors-in-hr-her2-high-ris-27638https://curecurrent.com/trials/imaging-of-primary-or-recurrent-breast-cancer-with-18f-fluorthanatrace-pet-ct-27639https://curecurrent.com/trials/clinical-translation-research-on-a-multi-omics-breast-cancer-distant-metastasis-prediction-model-empowered-by-artificial-27640https://curecurrent.com/trials/a-study-to-investigate-the-effect-of-capivasertib-on-the-pharmacokinetics-of-oral-rosuvastatin-in-healthy-participants-27641https://curecurrent.com/trials/a-single-arm-open-label-multicenter-phase-ib-ii-clinical-trial-of-cvl237-tablets-in-combination-with-serplulimab-injecti-27642https://curecurrent.com/trials/a-phase-ii-single-arm-study-to-evaluate-the-efficacy-and-safety-of-inavolisib-in-combination-with-eribulin-in-pretreated-27643https://curecurrent.com/trials/a-single-arm-prospective-phase-ii-clinical-study-of-the-combination-of-entinostat-and-oral-paclitaxel-in-the-treatment-o-27644https://curecurrent.com/trials/mediterranean-diet-and-physical-activity-in-breast-cancer-patients-under-hormone-therapy-27645https://curecurrent.com/trials/a-phase-1-2-clinical-trial-to-assess-the-safety-tolerability-pharmacokinetics-and-preliminary-efficacy-of-hmbd-501-in-pa-27646https://curecurrent.com/trials/optimal-mammography-view-sequencing-in-women-with-a-history-of-breast-cancer-undergoing-surveillance-mammography-27647https://curecurrent.com/trials/a-trial-of-hrs-2189-in-combination-with-fluvastatin-hrs-6209-or-hrs-8080-hrs-6209-or-hrs-6209-hrs-1358-in-breast-cancer-27648https://curecurrent.com/trials/study-of-her2-directed-dendritic-cell-dc1-vaccine-weekly-paclitaxel-trastuzumab-pertuzumab-27649https://curecurrent.com/trials/ql1706-plus-chemotherapy-as-neoadjuvant-therapy-in-triple-negative-breast-cancer-27650https://curecurrent.com/trials/heartphone-cancer-survivors-trial-2019-27651https://curecurrent.com/trials/does-immediate-lymphatic-reconstruction-decrease-the-risk-of-lymphedema-after-axillary-lymph-node-dissection-27652https://curecurrent.com/trials/comparative-study-between-sglt-2i-and-dpp-4i-in-the-prevention-of-dic-27653https://curecurrent.com/trials/cryoablation-vs-lumpectomy-in-t1-breast-cancers-27654https://curecurrent.com/trials/sexual-health-and-breast-cancer-developing-appropriate-education-for-women-going-through-treatment-27655https://curecurrent.com/trials/fes-bpet-dbt-in-newly-diagnosed-breast-cancer-27656https://curecurrent.com/trials/a-study-of-and019-in-women-with-er-positive-her2-negative-advanced-or-metastatic-breast-cancer-27657https://curecurrent.com/trials/the-aiur-trial-surgical-gloves-to-prevent-peripheral-neuropathy-27658https://curecurrent.com/trials/a-global-study-to-compare-the-effects-of-fulvestrant-and-arimidex-in-a-subset-of-patients-with-breast-cancer-27659https://curecurrent.com/trials/food-related-quality-of-life-in-patients-with-cancer-27660https://curecurrent.com/trials/stereotactic-guided-biopsy-and-cryoablation-27661https://curecurrent.com/trials/gait-characteristics-of-women-with-breast-cancer-related-lymphedema-27662https://curecurrent.com/trials/trial-to-evaluate-an-educational-video-series-for-women-in-breast-cancer-treatment-27663https://curecurrent.com/trials/her2-bats-and-pembrolizumab-in-metastatic-breast-cancer-27664https://curecurrent.com/trials/treatment-and-monitoring-patterns-and-clinical-outcomes-in-patients-receiving-palbociclib-combination-treatment-with-ai-27665https://curecurrent.com/trials/study-of-rp2-monotherapy-and-rp2-in-combination-with-nivolumab-in-patients-with-solid-tumors-27666https://curecurrent.com/trials/investigating-the-effectiveness-of-stereotactic-body-radiotherapy-sbrt-in-addition-to-standard-of-care-treatment-for-can-27667https://curecurrent.com/trials/contrast-enhanced-stereotactic-biopsy-27668https://curecurrent.com/trials/metronomic-capecitabine-plus-aromatase-inhibitor-for-first-line-treatment-in-hr-her2-metastatic-breast-cancer-27669https://curecurrent.com/trials/exploring-the-effects-of-shangshou-daoyin-method-on-improving-sleep-quality-quality-of-life-and-tcm-constitution-in-brea-27670https://curecurrent.com/trials/cancer-peptides-plus-gm-csf-and-adjuvant-in-breast-cancer-27671https://curecurrent.com/trials/2d-4d-finger-ratio-and-breast-cancer-in-women-27672https://curecurrent.com/trials/first-in-human-positron-emission-tomography-study-using-the-18f-v-6-binding-peptide-27673https://curecurrent.com/trials/metastases-directed-radiotherapy-in-addition-to-standard-systemic-therapy-in-patients-with-oligometastatic-breast-cancer-27674https://curecurrent.com/trials/ds-8201a-in-pre-treated-her2-breast-cancer-that-cannot-be-surgically-removed-or-has-spread-destiny-breast02-27675https://curecurrent.com/trials/smart-bra-for-diagnosing-breast-cancer-27676https://curecurrent.com/trials/de-escalation-of-neoadjuvant-treatment-paclitaxel-hp-in-early-her2-breast-cancer-27677https://curecurrent.com/trials/impact-of-neoadjuvant-chemotherapy-on-the-peripheral-blood-immune-phenotype-in-operable-breast-cancer-27678https://curecurrent.com/trials/abbreviated-breast-mri-and-digital-tomosynthesis-mammography-in-screening-women-with-dense-breasts-27679https://curecurrent.com/trials/posaconazole-plus-pd-1-inhibitors-and-chemotherapy-vs-pd-1-inhibitors-and-chemotherapy-in-neoadjuvant-therapy-for-triple-27680https://curecurrent.com/trials/brca1-rassf1a-and-pten-methylation-in-breast-lesions-of-uncertain-malignant-potential-27681https://curecurrent.com/trials/topical-tranexamic-acid-with-flap-fixation-a-novel-approach-to-minimize-post-operative-drainage-and-surgical-site-infect-27682https://curecurrent.com/trials/collection-of-specimens-and-clinical-data-for-patients-with-recurrent-or-metastatic-breast-cancer-or-male-breast-cancer-27683https://curecurrent.com/trials/with-love-grandma-con-cari-o-abuelita-pilot-study-27684https://curecurrent.com/trials/a-study-of-enzalutamide-enzalutamide-in-combination-with-mifepristone-or-chemotherapy-in-people-with-metastatic-breast-c-27685https://curecurrent.com/trials/testing-conversation-aid-in-practice-27686https://curecurrent.com/trials/safety-study-of-melk-inhibitor-to-treat-patients-with-advanced-breast-cancer-and-triple-negative-breast-cancer-27687https://curecurrent.com/trials/rehabilitation-for-people-with-advanced-cancer-27688https://curecurrent.com/trials/ibi354-with-or-without-pertuzumab-versus-taxane-trastuzumab-and-pertuzumab-in-her2-positive-metastatic-breast-cancer-27689https://curecurrent.com/trials/safe-and-explainable-ai-27690https://curecurrent.com/trials/amtec-iit-phase-2-multiarm-study-in-tnbc-27691https://curecurrent.com/trials/pembrolizumab-endocrine-therapy-and-palbociclib-in-treating-postmenopausal-patients-with-newly-diagnosed-metastatic-stag-27692https://curecurrent.com/trials/axillary-lymph-node-changes-after-neoadjuvant-therapy-in-breast-cancer-27693https://curecurrent.com/trials/first-in-human-study-of-atx-559-an-oral-inhibitor-of-dhx9-in-patients-with-advanced-or-metastatic-solid-tumors-and-molec-27694https://curecurrent.com/trials/prehabilitation-in-breast-cancer-surgery-27695https://curecurrent.com/trials/preventing-lymphedema-in-axillary-lymph-node-dissection-27696https://curecurrent.com/trials/a-window-of-opportunity-trial-of-giredestrant-triptorelin-vs-anastrozole-triptorelin-in-premenopausal-patients-with-er-p-27697https://curecurrent.com/trials/web-based-application-for-monitoring-radiation-therapy-complications-in-cancer-patients-27698https://curecurrent.com/trials/azd2014-and-fulvestrant-in-patients-with-er-advanced-metastatic-breast-cancer-27699https://curecurrent.com/trials/a-single-arm-phase-ii-trial-of-sacituzumab-govitecan-and-trastuzumab-for-her2-metastatic-breast-cancer-after-trastuzumab-27700https://curecurrent.com/trials/prospective-ultrasound-data-collection-study-for-ai-based-detection-of-breast-biopsy-markers-27701https://curecurrent.com/trials/patient-recall-of-cancer-screening-and-diagnosis-27702https://curecurrent.com/trials/hypofractionated-radiation-therapy-after-mastectomy-in-preventing-recurrence-in-patients-with-stage-iia-iiia-breast-canc-27703https://curecurrent.com/trials/acceptability-and-feasibility-of-psc-model-of-serious-illness-communication-27704https://curecurrent.com/trials/culturally-aware-aet-non-initiation-intervention-27705https://curecurrent.com/trials/preventing-chemotherapy-induced-peripheral-neuropathy-with-acupuncture-pact-trial-27706https://curecurrent.com/trials/phase-2-study-of-amcenestrant-sar439859-versus-physician-s-choice-in-locally-advanced-or-metastatic-er-positive-breast-c-27707https://curecurrent.com/trials/extracellular-fluid-changes-during-neoadjuvant-chemotherapy-27708https://curecurrent.com/trials/robotic-vs-open-nsm-for-early-stage-breast-cancer-27709https://curecurrent.com/trials/predicting-pathologic-complete-response-to-neoadjuvant-chemotherapy-in-breast-cancer-using-machine-learning-models-27710https://curecurrent.com/trials/enhancing-shared-decision-making-in-metastatic-breast-cancer-qualitative-study-27711https://curecurrent.com/trials/lymph-node-identification-using-magtrace-and-magseed-before-chemotherapy-27712https://curecurrent.com/trials/study-of-pik3ca-mutations-and-effectiveness-and-tolerability-outcomes-of-alpelisib-in-real-world-27713https://curecurrent.com/trials/the-effects-of-treating-insomnia-on-behavioral-weight-loss-outcomes-in-survivors-of-breast-cancer-27714https://curecurrent.com/trials/pq203-in-advanced-malignant-tumors-including-triple-negative-breast-cancer-27715https://curecurrent.com/trials/tucatinib-trastuzumab-and-capecitabine-with-brain-and-or-spinal-radiotherapy-xrt-in-patients-with-her2-her2-mutated-and-27716https://curecurrent.com/trials/iris-risk-based-imaging-after-breast-conserving-surgery-27717https://curecurrent.com/trials/real-world-treatment-experience-of-patients-with-breast-lung-or-gi-cancer-or-multiple-myeloma-using-remote-symptom-monit-27718https://curecurrent.com/trials/interview-of-patients-with-hr-her2-metastatic-breast-cancer-who-received-capivasertib-fulvestrant-27719https://curecurrent.com/trials/olaparib-sapacitabine-in-brca-mutant-breast-cancer-27720https://curecurrent.com/trials/real-world-treatment-experience-of-patients-with-breast-lung-ovarian-multiple-myeloma-or-acute-myelogenous-leukemia-usin-27721https://curecurrent.com/trials/tucatinib-and-trastuzumab-in-her3-mutant-and-her2-not-amplified-metastatic-breast-cancer-27722https://curecurrent.com/trials/the-active-after-cancer-trial-aact-27723https://curecurrent.com/trials/oncology-episode-payment-model-in-hawaii-27724https://curecurrent.com/trials/chemotherapy-and-stem-cell-transplantation-in-treating-patients-with-stage-iiib-breast-cancer-27725https://curecurrent.com/trials/her-2-pulsed-dc-vaccine-to-prevent-recurrence-of-invasive-breast-cancer-27726https://curecurrent.com/trials/the-effect-of-neoadjuvant-chemotherapy-on-physical-functions-27727https://curecurrent.com/trials/circulating-tumor-dna-ctdna-for-early-treatment-response-assessment-of-solid-tumors-27728https://curecurrent.com/trials/ctdna-guided-chemotherapy-omission-with-ribociclib-plus-endocrine-therapy-in-hr-positive-her2-negative-breast-cancer-27729https://curecurrent.com/trials/diagnostic-her2dx-guided-treatment-for-patients-with-early-stage-her2-positive-breast-cancer-27730https://curecurrent.com/trials/additional-imaging-methods-for-assessing-axillary-lymph-node-involvement-in-breast-cancer-27731https://curecurrent.com/trials/study-evaluating-dna-double-strand-breaks-dsbs-repair-factors-polq-shieldin-complex-and-53bp1-expression-as-biomarker-of-27732https://curecurrent.com/trials/a-study-of-itc-6146ro-in-patients-with-advanced-or-metastatic-cancer-who-have-failed-standard-therapy-27733https://curecurrent.com/trials/gammapod-dose-escalation-radiation-for-early-stage-breast-cancer-27734https://curecurrent.com/trials/theranostic-approach-by-early-multigene-sequencing-in-advanced-poor-prognosis-cancers-27735https://curecurrent.com/trials/step-count-and-treatment-response-in-neoadjuvant-breast-cancer-27736https://curecurrent.com/trials/three-fraction-radiation-to-induce-immuno-oncologic-response-27737https://curecurrent.com/trials/neoadjuvant-letrozole-in-postmenopausal-women-with-hormone-receptor-positive-her2-negative-node-positive-early-stage-bre-27738https://curecurrent.com/trials/abemaciclib-for-patients-with-retinoblastoma-positive-triple-negative-metastatic-breast-cancer-27739https://curecurrent.com/trials/a-two-arm-study-to-evaluate-the-pharmacokinetics-efficacy-and-safety-of-subcutaneous-administration-of-the-fixed-dose-co-27740https://curecurrent.com/trials/gammapod-registry-and-quality-of-life-nomogram-27741https://curecurrent.com/trials/precision-oncology-clinical-diagnostic-study-in-primary-and-metastatic-breast-cancer-prism-27742https://curecurrent.com/trials/fdg-pet-ct-vs-ct-for-monitoring-metastatic-breast-cancer-27743https://curecurrent.com/trials/preoperative-shoulder-exercises-and-postoperative-inflammation-pain-and-function-after-modified-radical-mastectomy-27744https://curecurrent.com/trials/axillary-node-dissection-w-or-w-o-lvb-in-node-positive-breast-cancer-patients-27745https://curecurrent.com/trials/long-term-followup-of-patients-enrolled-in-mc1137-beauty-study-27746https://curecurrent.com/trials/opening-the-conversation-study-27747https://curecurrent.com/trials/ultrasound-guided-pecs-block-and-ketamine-infusion-for-preventing-chronic-pain-in-patients-undergoing-breast-cancer-surg-27748https://curecurrent.com/trials/web-based-symptom-monitoring-and-self-management-portal-yes-for-adolescent-and-young-adult-breast-cancer-survivors-27749https://curecurrent.com/trials/a-clinical-study-of-boserolimab-mk-5890-with-pembrolizumab-and-chemotherapy-in-people-with-early-triple-negative-breast-27750https://curecurrent.com/trials/a-platform-study-based-on-specific-tracer-for-evaluating-the-therapeutic-efficacy-of-systemic-treatment-for-breast-cance-27751https://curecurrent.com/trials/a-study-of-tumor-imaging-with-multispectral-optoacoustic-tomography-27752https://curecurrent.com/trials/evaluation-and-modeling-of-the-effect-of-g-csf-on-the-evolution-of-polynuclear-neutrophils-during-dense-dose-epirubicin-27753https://curecurrent.com/trials/patient-derived-breast-cancer-organoids-for-therapeutic-extracellular-vesicle-isolation-pdo-mercurial01-27754https://curecurrent.com/trials/177lu-anti-pd-l1-sdab-in-metastatic-solid-tumors-27755https://curecurrent.com/trials/correlation-between-tumor-infiltrating-lymphocytes-and-response-to-systemic-therapy-in-breast-cancer-27756https://curecurrent.com/trials/t-dm1-vs-paclitaxel-trastuzumab-for-breast-atempt-trial-27757https://curecurrent.com/trials/confirmatory-clinical-evaluation-of-novilase-laser-therapy-for-focal-destruction-of-malignant-breast-tumors-27758https://curecurrent.com/trials/grape-polyphenols-for-prevention-of-chemotherapy-induced-cardiotoxicity-27759https://curecurrent.com/trials/effectiveness-safety-and-tolerability-of-anti-her2-drugs-as-targeted-therapy-for-egyptian-patients-with-erbb2-positive-b-27760https://curecurrent.com/trials/biomarker-guided-allogeneic-single-target-or-dual-target-car-nk-cell-therapy-for-advanced-solid-tumors-27761https://curecurrent.com/trials/cfi-400945-and-durvalumab-in-patients-with-advanced-triple-negative-breast-cancer-27762https://curecurrent.com/trials/developing-an-internet-delivered-sexual-health-program-for-breast-cancer-survivors-shine-trial-27763https://curecurrent.com/trials/studying-the-role-of-circulating-tumor-cell-clusters-in-patients-with-high-risk-early-breast-cancer-study-galia-27764https://curecurrent.com/trials/neoadjuvant-imlunestrant-plus-abemaciclib-treatment-guided-by-ki67-index-after-2-weeks-for-er-positive-her2-negative-bre-27765https://curecurrent.com/trials/ebnk-001-allogeneic-nk-cells-with-low-dose-il-15-pembrolizumab-in-advanced-solid-tumors-27766https://curecurrent.com/trials/trastuzumab-rezetecan-vs-trastuzumab-deruxtecan-in-the-neoadjuvant-treatment-of-her2-positive-breast-cancer-27767https://curecurrent.com/trials/cancer-genetics-hereditary-cancer-panel-testing-27768https://curecurrent.com/trials/shr-a1811-vs-pyrotinib-capecitabine-in-trastuzumab-resistant-her2-advanced-breast-cancer-a-randomized-study-27769https://curecurrent.com/trials/phase-1-2-dose-finding-safety-and-pk-study-in-advanced-refractory-solid-tumors-27770https://curecurrent.com/trials/a-study-of-radiation-therapy-with-pembrolizumab-and-olaparib-or-other-radiosensitizers-in-women-who-have-triple-negative-27771https://curecurrent.com/trials/preoperative-magnetic-tracking-in-breast-surgery-in-france-french-medical-economic-study-27772https://curecurrent.com/trials/immune-tumor-stroma-factors-and-pathologic-complete-response-after-neoadjuvant-chemotherapy-in-early-breast-cancer-27773https://curecurrent.com/trials/a-study-of-the-use-of-acellular-dermal-matrix-for-breast-reconstruction-27774https://curecurrent.com/trials/topical-dermaprazole-for-radiation-dermatitis-in-breast-cancer-patients-topaz-27775https://curecurrent.com/trials/vaccine-therapy-in-treating-patients-with-her2-negative-stage-iii-iv-breast-cancer-27776https://curecurrent.com/trials/delayed-breast-reconstruction-by-prepectoral-implant-after-lipo-preparation-rm2prepec-27777https://curecurrent.com/trials/nearwave-optical-molecular-monitoring-27778https://curecurrent.com/trials/a-study-on-predicting-the-risk-of-distant-metastasis-in-breast-cancer-using-ai-generated-spatial-pathological-maps-27779https://curecurrent.com/trials/a-patient-navigation-program-for-addressing-disparities-in-breast-cancer-care-27780https://curecurrent.com/trials/reducing-dexamethasone-around-docetaxel-infusion-27781https://curecurrent.com/trials/breast-density-impact-on-mammographic-screening-for-breast-cancer-diagnosis-27782https://curecurrent.com/trials/reproductive-health-in-breast-cancer-survivor-27783https://curecurrent.com/trials/toxicity-outcomes-of-simultaneous-integrated-boost-in-adjuvant-breast-radiotherapy-acronym-27784https://curecurrent.com/trials/drug-drug-interaction-study-of-vorasidenib-with-bupropion-repaglinide-flurbiprofen-omeprazole-midazolam-and-rosuvastatin-27785https://curecurrent.com/trials/nab-paclitaxel-and-atezolizumab-before-surgery-in-treating-patients-with-triple-negative-breast-cancer-27786https://curecurrent.com/trials/assessing-the-efficacy-and-safety-of-anti-her2-therapy-in-nigerian-women-with-her2-breast-cancer-before-and-after-surger-27787https://curecurrent.com/trials/pharmacokinetics-and-safety-of-epidiferphane-and-taxanes-in-breast-cancer-patients-27788https://curecurrent.com/trials/trial-studying-chemotherapy-in-nigerian-women-with-triple-negative-breast-cancer-27789https://curecurrent.com/trials/phase-2-clinical-study-of-iparomlimab-and-tuvonralimab-ql1706-in-combination-with-platinum-chemotherapy-versus-platinum-27790https://curecurrent.com/trials/oral-contraceptive-oc-estrogen-dose-and-breast-proliferation-27791https://curecurrent.com/trials/pedicled-lateral-chest-wall-lymph-adipofascial-flap-to-prevent-arm-lymphedema-after-breast-cancer-surgery-27792https://curecurrent.com/trials/confirmation-of-the-link-between-endocrine-disruptors-exposure-and-breast-cancer-and-identification-of-biological-respon-27793https://curecurrent.com/trials/assessment-of-the-efficacy-and-safety-of-olaparib-monotherapy-versus-physicians-choice-chemotherapy-in-the-treatment-of-27794https://curecurrent.com/trials/a-study-of-tucatinib-given-before-surgery-to-people-with-her2-cancers-that-have-spread-to-the-brain-27795https://curecurrent.com/trials/breast-reconstruction-by-exclusive-lipomodulin-feasibility-evaluation-of-the-aesthetic-result-and-quality-of-life-27796https://curecurrent.com/trials/no-axillary-surgical-treatment-in-clinically-lymph-node-negative-patients-after-ultrasonography-27797https://curecurrent.com/trials/impact-of-an-artificial-intelligence-based-management-model-on-psychological-and-behavioral-outcomes-in-breast-cancer-pa-27798https://curecurrent.com/trials/multicomponent-care-for-aromatase-inhibitor-related-musculoskeletal-symptoms-27799https://curecurrent.com/trials/gradient-echo-spectroscopic-imaging-study-of-saturated-fat-and-breast-cancer-27800https://curecurrent.com/trials/ai-enhanced-imaging-in-population-breast-cancer-screening-27801https://curecurrent.com/trials/phase-ii-exploratory-study-of-toripalimab-combined-with-sbrt-in-her2-negative-breast-cancer-patients-with-insensitivity-27802https://curecurrent.com/trials/hobbit-3-mental-exercises-and-temporal-alteration-27803https://curecurrent.com/trials/copper-cu-64-dota-trastuzumab-pet-in-predicting-response-to-treatment-with-ado-trastuzumab-emtansine-in-patients-with-me-27804https://curecurrent.com/trials/pain-and-functional-recovery-after-mastectomy-and-ibr-by-implant-prepectoral-versus-subpectoral-technique-27805https://curecurrent.com/trials/nonpharmacological-management-of-pain-and-fear-during-hormone-injection-in-breast-cancer-patients-27806https://curecurrent.com/trials/a-study-of-clsp-1025-in-adult-patients-with-solid-tumors-that-harbor-the-p53-r175h-mutation-27807https://curecurrent.com/trials/neoadjuvant-carbo-paclitaxel-followed-by-doxorubicin-cyclophosphamide-in-breast-cancer-27808https://curecurrent.com/trials/effects-of-a-cognitive-training-program-on-chemotherapy-induced-cognitive-impairment-chemobrain-in-breast-cancer-patient-27809https://curecurrent.com/trials/mammoscreen-breast-cancer-risk-assessment-and-decision-aid-for-breast-cancer-screening-and-referrals-27810https://curecurrent.com/trials/comparison-of-safety-and-patients-reported-outcomes-between-single-port-endoscopic-and-conventional-nipple-sparing-maste-27811https://curecurrent.com/trials/mobile-health-app-to-promote-participation-of-black-women-in-breast-cancer-clinical-trials-27812https://curecurrent.com/trials/immunotherapy-related-crp-kinetics-in-early-and-metastatic-triple-negative-breast-cancer-27813https://curecurrent.com/trials/efficacy-and-safety-of-dexmedetomidine-added-to-modified-pectoral-s-block-27814https://curecurrent.com/trials/tirzepatide-weight-loss-for-mrd-early-breast-cancer-27815https://curecurrent.com/trials/umbrella-trial-of-subtype-targeted-therapies-in-er-her2-breast-cancer-27816https://curecurrent.com/trials/laser-acupuncture-on-carpal-tunnel-syndrome-27817https://curecurrent.com/trials/evaluation-of-the-effectiveness-of-managing-chemotherapy-side-effects-using-epro-and-a-standardized-telenursing-program-27818https://curecurrent.com/trials/clinical-validation-of-ai-assisted-radiotherapy-contouring-software-for-thoracic-organs-at-risk-27819https://curecurrent.com/trials/bortezomib-followed-by-pembrolizumab-and-cisplatin-in-mettnbc-27820https://curecurrent.com/trials/avi-didactic-experience-for-latinx-patient-treatment-adherence-and-non-english-speaker-trial-enrollment-study-in-rad-onc-27821https://curecurrent.com/trials/study-on-the-impact-of-electroacupuncture-combined-with-self-acupressure-on-the-quality-of-life-of-patients-with-early-s-27822https://curecurrent.com/trials/a-phase-iii-study-of-sys6010-versus-chemotherapy-in-her2-negative-egfr-positive-recurrent-or-metastatic-breast-cancer-27823https://curecurrent.com/trials/neratinib-and-paclitaxel-with-or-without-pertuzumab-and-trastuzumab-before-combination-chemotherapy-in-treating-patients-27824https://curecurrent.com/trials/phase-ii-prospective-randomized-proof-of-concept-study-to-evaluate-the-effects-of-a-personalized-dietary-intervention-in-27825https://curecurrent.com/trials/evaluating-the-use-of-a-medication-switch-vs-guideline-directed-interventions-for-relieving-side-effects-of-aromatase-in-27826https://curecurrent.com/trials/a-study-of-mr001-in-patients-with-locally-recurrent-or-metastatic-advanced-triple-negative-breast-cancer-tnbc-27827https://curecurrent.com/trials/triaging-of-women-detected-with-a-breast-lump-on-clinical-breast-examination-using-portable-ultrasound-device-27828https://curecurrent.com/trials/a-randomised-trial-comparing-trastuzumab-deruxtecan-to-cdk4-6-inhibitors-in-non-luminal-a-er-positive-her2-low-metastati-27829https://curecurrent.com/trials/evaluation-of-the-performance-and-safety-of-hyalo-gyn-gel-compared-to-placebo-in-postmenopausal-breast-cancer-survivors-27830https://curecurrent.com/trials/randomized-open-label-clinical-study-of-the-targeted-therapy-palbociclib-to-treat-metastatic-breast-cancer-27831https://curecurrent.com/trials/real-world-studies-of-cdk4-6-inhibitors-27832https://curecurrent.com/trials/step-by-step-after-cancer-27833https://curecurrent.com/trials/gut-microbiome-changes-during-abemaciclib-therapy-in-breast-cancer-27834https://curecurrent.com/trials/adjuvant-intensification-for-lar-27835https://curecurrent.com/trials/a-trial-of-lbl-024-monotherapy-or-combination-drug-in-patients-with-triple-negative-breast-cancer-27836https://curecurrent.com/trials/personalized-treatment-of-high-risk-mammary-cancer-the-petremac-trial-27837https://curecurrent.com/trials/study-of-infigratinib-in-combination-with-tamoxifen-in-hormone-receptor-positive-her2-negative-fgfr-altered-advanced-bre-27838https://curecurrent.com/trials/fhir-enhanced-realrisks-to-improve-accuracy-of-breast-cancer-risk-assessments-27839https://curecurrent.com/trials/evaluation-of-her2dx-assay-on-treatment-decisions-in-patients-with-early-stage-her2-breast-cancer-the-her2breastdx-27840https://curecurrent.com/trials/onvansertib-paclitaxel-in-tnbc-27841https://curecurrent.com/trials/stereotactic-image-guided-neoadjuvant-ablative-radiation-then-lumpectomy-27842https://curecurrent.com/trials/clinical-feasibility-of-mobile-app-based-self-management-for-breast-cancer-related-lymphedema-27843https://curecurrent.com/trials/stereotactic-body-radiotherapy-for-extracranial-oligometastatic-breast-cancer-multi-institutional-retrospective-database-27844https://curecurrent.com/trials/a-study-of-postoperative-regional-nodal-radiotherapy-in-intermediate-risk-breast-cancer-27845https://curecurrent.com/trials/response-based-local-therapy-for-regionally-advanced-breast-cancer-27846https://curecurrent.com/trials/development-implementation-and-evaluation-of-an-individual-decision-aid-in-swedish-cancer-screening-programs-27847https://curecurrent.com/trials/neoadjuvant-sbrt-with-intratumoural-pembrolizumab-followed-by-neoadjuvant-chemotherapy-in-breast-cancer-27848https://curecurrent.com/trials/feasibility-study-for-the-sira-1000-sira-rfa-electrosurgical-device-as-an-adjunct-to-breast-conserving-surgery-27849https://curecurrent.com/trials/palbociclib-pharmacokinetics-study-in-postmenopausal-chinese-women-with-er-her2-advanced-breast-cancer-27850https://curecurrent.com/trials/fasting-mimicking-diet-intervention-on-side-effects-of-aromatase-inhibitors-treatment-in-patients-with-breast-cancer-27851https://curecurrent.com/trials/a-study-to-evaluate-patient-preference-for-home-administration-of-fixed-dose-combination-of-pertuzumab-and-trastuzumab-f-27852https://curecurrent.com/trials/breast-cancer-organelle-properties-and-protein-expression-atlas-in-the-three-immunohistochemical-subtypes-of-breast-canc-27853https://curecurrent.com/trials/use-of-a-virtual-reality-cognitive-stimulation-programme-for-breast-cancer-patients-wishing-to-restart-or-maintain-a-pro-27854https://curecurrent.com/trials/vepdegestrant-arv-471-pf-07850327-palbociclib-vs-letrozole-palbociclib-in-er-her2-advanced-breast-cancer-27855https://curecurrent.com/trials/gedatolisib-plus-fulvestrant-with-or-without-palbociclib-vs-standard-of-care-for-the-treatment-of-patients-with-advanced-27856https://curecurrent.com/trials/rhomboid-intercostal-sub-serratus-plane-blocks-and-erector-spinae-plane-block-in-mastectomy-surgeries-27857https://curecurrent.com/trials/a-phase-i-ii-study-of-fwd1802-in-patients-with-er-her2-advanced-bc-27858https://curecurrent.com/trials/efficacy-and-safety-of-extended-dose-interval-immunotherapy-versus-standard-dose-interval-immunotherapy-for-advanced-tri-27859https://curecurrent.com/trials/conformal-ablative-radiotherapy-in-older-women-carmen-with-breast-cancer-undergoing-non-operative-management-27860https://curecurrent.com/trials/a-prospective-study-of-video-assisted-exercise-program-for-the-breast-cancer-survivors-27861https://curecurrent.com/trials/cdk4-6-inhibitors-in-breast-cancer-elderly-patients-an-observational-ambispective-longitudinal-multicenter-study-27862https://curecurrent.com/trials/s1207-hormone-therapy-with-or-without-everolimus-in-treating-patients-with-breast-cancer-27863https://curecurrent.com/trials/impact-of-endocrine-therapy-menstrual-cycle-pam50-ki67-on-treatment-decisions-in-hr-and-her2-breast-cancer-27864https://curecurrent.com/trials/a-study-comparing-the-efficacy-and-safety-of-zanidatamab-to-trastuzumab-each-in-combination-with-physician-s-choice-chem-27865https://curecurrent.com/trials/breast-cancer-resiliency-through-exercise-program-b-rep-27866https://curecurrent.com/trials/study-of-neoadjuvant-endocrine-therapy-in-hr-positive-and-her2-negative-premenopausal-breast-cancer-patients-27867https://curecurrent.com/trials/focused-ultrasound-and-pembrolizumab-in-metastatic-breast-cancer-27868https://curecurrent.com/trials/p-muc1c-allo1-allogeneic-car-t-cells-in-the-treatment-of-subjects-with-advanced-or-metastatic-solid-tumors-27869https://curecurrent.com/trials/cardiotoxicity-in-breast-cancer-patients-treated-with-proton-or-photon-radiotherapy-a-radcomp-companion-study-27870https://curecurrent.com/trials/cipher-study-pilot-study-to-study-the-role-of-ctdna-in-triple-negative-and-her2-positive-early-stage-27871https://curecurrent.com/trials/pregnancy-outcome-and-safety-of-interrupting-therapy-for-women-with-endocrine-responsive-breast-cancer-27872https://curecurrent.com/trials/a-phase-1-2-study-of-st101-in-patients-with-advanced-solid-tumors-27873https://curecurrent.com/trials/study-on-the-treatment-of-her2-negative-breast-cancer-brain-metastases-with-radiotherapy-combined-with-anlotinib-27874https://curecurrent.com/trials/asian-study-of-sacituzumab-govitecan-immu-132-in-hr-her2-metastatic-breast-cancer-mbc-27875https://curecurrent.com/trials/cardiotoxicity-of-cancer-therapy-cct-27876https://curecurrent.com/trials/confirm-magnetic-resonance-guided-radiation-therapy-27877https://curecurrent.com/trials/a-study-of-abemaciclib-ly2835219-plus-tamoxifen-or-abemaciclib-alone-in-women-with-metastatic-breast-cancer-27878https://curecurrent.com/trials/neoadjuvant-trastuzumab-deruxtecan-shr-a1811-pertuzumab-in-her2-breast-cancer-27879https://curecurrent.com/trials/breastcancerpep-a-six-month-online-empowerment-program-to-improve-mental-and-physical-health-in-women-with-breast-cancer-27880https://curecurrent.com/trials/triptorelin-with-either-exemestane-or-tamoxifen-in-treating-premenopausal-women-with-hormone-responsive-breast-cancer-27881https://curecurrent.com/trials/combination-of-letrozole-everolimus-and-trc105-in-postmenopausal-women-with-hormone-receptor-positive-and-her2-negative-27882https://curecurrent.com/trials/binary-oncolytic-adenovirus-in-combination-with-her2-specific-autologous-car-vst-advanced-her2-positive-solid-tumors-27883https://curecurrent.com/trials/tiragolumab-atezolizumab-and-chemotherapy-in-triple-negative-breast-cancer-27884https://curecurrent.com/trials/breast-fractionation-study-standard-versus-investigational-fractionation-trial-nodal-radiation-27885https://curecurrent.com/trials/ctdna-guided-treatment-decision-making-27886https://curecurrent.com/trials/a-phase-iii-clinical-trial-of-ntq1062-in-combination-with-fulvestrant-for-the-treatment-of-advanced-or-metastatic-hr-her-27887https://curecurrent.com/trials/pembrolizumab-in-combination-with-olaparib-in-advanced-brca-mutated-or-hdr-defect-breast-cancer-27888https://curecurrent.com/trials/a-study-of-revaree-plus-in-people-with-breast-cancer-27889https://curecurrent.com/trials/dose-escalation-dose-expansion-study-of-prgn-3007-ultracar-t-cells-in-patients-with-advanced-hematologic-and-solid-tumor-27890https://curecurrent.com/trials/ultrasound-guided-pec-i-vs-sap-block-for-postoperative-analgesia-in-modified-radical-mastectomy-27891https://curecurrent.com/trials/breast-conserving-surgery-and-whole-breast-radiation-therapy-with-or-without-additional-radiation-therapy-to-the-tumor-i-27892https://curecurrent.com/trials/a-prospective-multicenter-registry-to-observe-the-treatment-patterns-clinical-outcomes-and-decision-making-in-patients-w-27893https://curecurrent.com/trials/cone-beam-breast-ct-for-breast-cancer-screening-27894https://curecurrent.com/trials/exercise-to-regain-stamina-and-energy-the-exergise-study-27895https://curecurrent.com/trials/a-study-of-abemaciclib-ly2835219-in-participants-with-breast-cancer-27896https://curecurrent.com/trials/evaluation-of-an-apoptotic-test-for-predicting-late-toxicities-after-radiotherapy-in-breast-and-prostate-cancer-patients-27897https://curecurrent.com/trials/the-mind-bc-study-mind-diet-for-breast-cancer-cognition-27898https://curecurrent.com/trials/paclitaxel-trastuzumab-pertuzumab-as-pre-op-for-inflammatory-brca-27899https://curecurrent.com/trials/telehealth-exercise-program-evaluating-fatigue-and-physical-function-in-rural-cancer-survivors-27900https://curecurrent.com/trials/patient-reported-outcomes-smart-pill-bottle-and-teleheath-for-endocrine-therapy-adherence-27901https://curecurrent.com/trials/ctnna1-familial-expansion-study-27902https://curecurrent.com/trials/decipher-trial-dc1-tx-for-early-stage-tnbc-and-er-low-positive-breast-cancer-27903https://curecurrent.com/trials/a-research-study-to-collect-patient-reported-outcomes-using-electronic-surveys-27904https://curecurrent.com/trials/nutrition-awareness-among-women-with-non-metastatic-breast-cancer-27905https://curecurrent.com/trials/feasibility-study-yoga-educational-project-27906https://curecurrent.com/trials/group-interventions-for-breast-cancer-survivors-27907https://curecurrent.com/trials/application-of-multimodal-mri-based-radiomics-in-histological-grading-and-prognostic-assessment-of-breast-cancer-27908https://curecurrent.com/trials/b-glucancer2-a-pilot-study-evaluating-a-new-method-for-cancer-detection-by-measuring-the-activity-of-different-glycosida-27909https://curecurrent.com/trials/a-study-of-sh009-injection-in-patients-with-advanced-solid-tumors-27910https://curecurrent.com/trials/exercise-rehabilitation-via-a-mobile-application-for-individuals-with-breast-cancer-undergoing-chemotherapy-27911https://curecurrent.com/trials/improving-care-for-rural-patients-with-solid-tumors-27912https://curecurrent.com/trials/prevention-of-postoperative-complications-by-negative-pressure-therapy-after-complex-breast-cancer-surgery-27913https://curecurrent.com/trials/management-of-perioperative-anxiety-by-the-cardiac-coherence-technique-coupled-with-a-hypnosis-session-27914https://curecurrent.com/trials/ketamine-versus-magnesium-sulphate-as-adjuvants-for-espb-in-breast-cancer-surgery-27915https://curecurrent.com/trials/randomized-study-of-stereotactic-body-radiation-therapy-sbrt-in-patients-with-oligoprogressive-metastatic-cancers-of-the-27916https://curecurrent.com/trials/impact-on-quality-of-life-and-health-of-the-continuum-connect-remote-monitoring-solution-27917https://curecurrent.com/trials/genetic-analysis-of-blood-and-tissue-samples-from-patients-with-advanced-cancer-moonshot-study-27918https://curecurrent.com/trials/preoperative-radiation-therapy-and-immediate-breast-reconstruction-27919https://curecurrent.com/trials/partial-breast-proton-therapy-for-early-stage-breast-cancer-27920https://curecurrent.com/trials/cognition-in-older-breast-cancer-survivors-treatment-exposure-apoe-and-smoking-history-27921https://curecurrent.com/trials/exert-bch-exercise-regimen-to-improve-muscle-mass-after-treatment-of-breast-cancer-27922https://curecurrent.com/trials/pi3k-pathway-activation-markers-in-er-positive-her2-negative-breast-cancer-a-clinicopathologic-study-27923https://curecurrent.com/trials/role-of-sodium-glucose-linked-transporter-2-sglt2-and-its-inhibitor-over-cardiotoxicity-induced-by-anthracyclines-and-br-27924https://curecurrent.com/trials/virtual-mental-health-intervention-to-address-fear-of-progression-for-women-with-high-risk-or-stage-iii-iv-gynecologic-o-27925https://curecurrent.com/trials/development-of-a-novel-graded-prognostic-assessment-bc-lgpa-model-for-breast-cancer-leptomeningeal-metastasis-27926https://curecurrent.com/trials/dalpiciclib-in-hr-her2-abc-27927https://curecurrent.com/trials/a-study-of-nonsteroidal-aromatase-inhibitors-plus-abemaciclib-ly2835219-in-postmenopausal-women-with-breast-cancer-27928https://curecurrent.com/trials/quantitative-microvasculature-imaging-for-breast-cancer-detection-and-monitoring-27929https://curecurrent.com/trials/prospective-biobanking-study-in-cancer-patients-aiming-at-better-understand-the-link-between-the-molecular-alterations-o-27930https://curecurrent.com/trials/ctcs-in-breast-cancer-after-neoadjuvant-treatment-and-surgery-a-multicenter-prospective-clinical-trial-27931https://curecurrent.com/trials/efficacy-of-onemark-device-in-identifying-breast-cancer-for-surgery-and-surveillance-27932https://curecurrent.com/trials/second-opinions-in-oncology-27933https://curecurrent.com/trials/gagne-learning-model-in-nursing-education-27934https://curecurrent.com/trials/neoadjuvant-therapy-combined-with-trastuzumab-rezetecan-and-toripalimab-for-hr-her2-low-breast-cancer-neotorch-breast-08-27935https://curecurrent.com/trials/famitinib-combined-with-shr-a1811-versus-shr-a1811-for-cdk4-6-inhibitors-resistent-advanced-hr-her2-breast-cancer-with-s-27936https://curecurrent.com/trials/resistance-training-and-post-workout-protein-to-improve-body-composition-during-neoadjuvant-chemotherapy-for-breast-canc-27937https://curecurrent.com/trials/portal-patient-reported-outcomes-after-routine-treatment-of-atypical-lesions-27938https://curecurrent.com/trials/the-young-women-s-breast-cancer-study-27939https://curecurrent.com/trials/pre-operative-exercise-during-neoadjuvant-chemotherapy-in-patients-with-breast-cancer-27940https://curecurrent.com/trials/effect-of-mandala-coloring-on-anxiety-distress-and-comfort-in-breast-cancer-patients-receiving-outpatient-chemotherapy-27941https://curecurrent.com/trials/efficacy-and-safety-of-qibei-jiedu-formula-for-preventing-and-managing-acute-radiation-dermatitis-in-breast-cancer-patie-27942https://curecurrent.com/trials/strategy-for-management-of-patients-with-hereditary-cancer-syndromes-hcs-in-a-rural-environment-27943https://curecurrent.com/trials/the-efficacy-and-safety-of-mecobalamin-in-the-prevention-of-capecitabine-induced-hand-foot-syndrome-27944https://curecurrent.com/trials/stereotactic-radiotherapy-for-oligoprogressive-er-her-metastatic-breast-cancer-a-prospective-phase-2-study-oligopro-brea-27945https://curecurrent.com/trials/hyperpolarized-carbon-13-based-metabolic-imaging-to-detect-radiation-induced-cardiotoxicity-27946https://curecurrent.com/trials/partial-breast-irradiation-using-interstitial-permanent-palladium-103-seed-implant-27947https://curecurrent.com/trials/effects-of-concentric-cycling-training-protocol-during-neo-adjuvant-chemotherapy-in-breast-cancer-patients-protect-07-st-27948https://curecurrent.com/trials/contrast-enhanced-ultrasound-medical-imaging-for-identifying-breast-masses-27949https://curecurrent.com/trials/study-of-sacituzumab-govitecan-in-chinese-patients-with-metastatic-triple-negative-breast-cancer-who-received-at-least-t-27950https://curecurrent.com/trials/stress-reactivity-among-african-american-breast-cancer-survivors-27951https://curecurrent.com/trials/developing-a-comprehensive-exercise-service-for-breast-cancer-process-27952https://curecurrent.com/trials/a-prospective-study-to-evaluate-continuous-positive-airway-pressure-devices-to-reduce-pulmonary-dose-27953https://curecurrent.com/trials/comparison-of-vr-cpt-with-and-without-lifestyle-modification-on-uld-in-breast-cancer-survivors-27954https://curecurrent.com/trials/acupuncture-and-compression-for-the-prevention-of-cipn-in-breast-cancer-patients-27955https://curecurrent.com/trials/identification-of-breast-cancer-specific-markers-in-patients-compared-to-healthy-participants-27956https://curecurrent.com/trials/a-study-of-sacituzumab-govitecan-given-at-an-alternative-dose-and-schedule-in-participants-with-advanced-triple-negative-27957https://curecurrent.com/trials/breast-cancer-and-chemobrain-effects-of-photobiomodulation-on-the-improvement-of-perceived-cognitive-impairment-27958https://curecurrent.com/trials/plant-based-diets-and-risk-of-cancer-in-the-adventist-health-study-2-27959https://curecurrent.com/trials/praegnant-breast-cancer-early-advanced-metastatic-27960https://curecurrent.com/trials/monitoring-for-cancer-spread-to-the-central-nervous-system-cns-in-people-with-breast-cancer-27961https://curecurrent.com/trials/x-ray-psoralen-activated-cancer-therapy-in-head-and-neck-breast-sarcoma-and-melanoma-27962https://curecurrent.com/trials/evaluation-of-see-d-as-an-automated-blood-sample-preparator-for-multiple-liquid-biopsy-applications-27963https://curecurrent.com/trials/validation-of-a-prognostic-method-for-assessing-the-risk-of-distant-metastasis-in-early-stage-breast-cancer-27964https://curecurrent.com/trials/harnessing-analysis-rna-expression-and-molecular-subtype-to-optimize-novel-therapy-mbca-27965https://curecurrent.com/trials/opioid-free-versus-opioid-based-anaesthesia-for-free-flap-reconstruction-surgery-of-the-breast-a-phase-iii-multicentric-27966https://curecurrent.com/trials/personalized-mammographic-screening-in-norway-27967https://curecurrent.com/trials/telmisartan-for-prevention-of-doxorubicin-induced-cardiotoxicity-in-breast-cancer-patients-27968https://curecurrent.com/trials/the-immune-system-s-response-to-young-women-s-breast-cancer-27969https://curecurrent.com/trials/preoperative-localization-of-infraclinical-breast-tumors-isotopic-localization-by-iodine125-seed-versus-standard-localiz-27970https://curecurrent.com/trials/concordance-of-the-biology-of-primary-breast-carcinoma-and-the-biology-of-recurrence-27971https://curecurrent.com/trials/a-study-of-hb0025-plus-nab-paclitaxel-as-first-line-therapy-for-tnbc-27972https://curecurrent.com/trials/window-of-opportunity-study-targeting-the-inflammatory-milieu-27973https://curecurrent.com/trials/the-effect-of-mobile-based-care-and-monitoring-on-lymphatic-edema-management-and-quality-of-life-in-breast-surgery-27974https://curecurrent.com/trials/stress-test-in-detecting-heart-damage-in-premenopausal-women-with-stage-i-iii-breast-cancer-27975https://curecurrent.com/trials/per-operative-radiotherapy-by-papillon-tm-in-localized-breast-cancer-27976https://curecurrent.com/trials/abemaciclib-and-niraparib-before-surgery-for-the-treatment-of-hormone-receptor-positive-her2-negative-breast-cancer-27977https://curecurrent.com/trials/acutherapy-to-prevent-aromatase-inhibitor-associated-arthralgias-in-non-hispanic-black-postmenopausal-women-with-early-s-27978https://curecurrent.com/trials/clinical-study-to-assess-the-efficacy-and-pressure-maintenance-of-mobiderm-autofit-versus-bandages-in-the-management-of-27979https://curecurrent.com/trials/diet-hepcidin-and-chemotherapy-rdi-27980https://curecurrent.com/trials/fertility-outcomes-in-young-breast-cancer-patients-and-their-prognosis-and-offspring-health-27981https://curecurrent.com/trials/sharon-a-clinical-trial-for-metastatic-cancer-using-chemotherapy-and-patients-own-stem-cells-27982https://curecurrent.com/trials/a-study-of-changes-in-pd-l1-expression-during-preoperative-treatment-with-nab-paclitaxel-and-pembrolizumab-in-hormone-re-27983https://curecurrent.com/trials/efficacy-of-personalized-tumorogram-based-therapy-in-cancer-established-from-patient-derived-organoid-avatar-27984https://curecurrent.com/trials/the-prognostic-impact-of-her2-expression-in-non-metastatic-her2-positive-breast-cancer-treated-with-dual-her2-targeted-t-27985https://curecurrent.com/trials/pectoral-nerve-block-and-serratus-posterior-superior-intercostal-plane-block-in-breast-cancer-surgery-27986https://curecurrent.com/trials/fulvestrant-abemaciclib-with-run-in-of-fulvestrant-in-er-positive-her2-negative-metastatic-breast-cancer-27987https://curecurrent.com/trials/fluorizoparib-plus-apatinib-versus-chemotherapy-in-hrd-positive-her2-negative-advanced-breast-cancer-27988https://curecurrent.com/trials/no-axillary-surgical-treatment-in-clinically-lymph-node-negative-patients-on-ultrasonography-after-neoadjuvant-chemother-27989https://curecurrent.com/trials/symptom-management-and-transitioning-to-engagement-with-post-treatment-care-for-adolescent-and-young-adult-cancer-surviv-27990https://curecurrent.com/trials/creatine-and-cognitive-health-in-patients-with-early-stage-breast-cancer-during-and-after-chemotherapy-treatment-27991https://curecurrent.com/trials/effect-of-continuous-intraoperative-esketamine-infusion-on-perioperative-negative-emotions-in-breast-cancer-surgery-pati-27992https://curecurrent.com/trials/brain-functional-mri-in-older-women-with-breast-cancer-brain-fmri-bc-27993https://curecurrent.com/trials/study-of-sacituzumab-govitecan-with-atropine-to-improve-tolerability-in-advanced-tnbc-and-hr-her2-breast-cancer-27994https://curecurrent.com/trials/sexual-health-empowerment-for-women-s-health-27995https://curecurrent.com/trials/tme-alteration-in-her2-positive-breast-cancer-27996https://curecurrent.com/trials/sequencing-sg-vs-t-dxd-in-her2-low-trop2-high-metastatic-breast-cancer-27997https://curecurrent.com/trials/effect-of-esketamine-on-perioperative-negative-emotions-in-breast-cancer-surgery-patients-with-severe-depression-27998https://curecurrent.com/trials/continuous-positive-airway-pressure-cpap-assisted-radiotherapy-in-breast-cancer-27999https://curecurrent.com/trials/sexual-health-in-breast-cancer-patients-28000